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ABSTRACT 
THE ROLE OF HIPPOCAMPAL AND MEDIAL PREFRONTAL INTERACTIONS IN THE ESTROGENIC 
REGULATION OF MEMORY  
 
by 
Jennifer Tuscher 
 
The University of Wisconsin-Milwaukee, 2017 
Under the Supervision of Dr. Karyn M. Frick 
 
 
Dendritic spine plasticity is thought to be essential for the formation and storage of memories. 
The sex-steroid hormone 17-estradiol (E2) increases dendritic spine density in 2 brain regions 
necessary for memory formation, the dorsal hippocampus (DH) and medial prefrontal cortex 
(mPFC), but the mechanisms through which it does so remain largely unknown. Further, the 
extent to which these brain regions interact to mediate E2’s effects on memory is also unclear. 
Recently, we found that infusion of E2 directly into the DH also increases dendritic spine density 
in the DH and mPFC, and that these effects depend upon rapid activation of the extracellular 
signal-regulated kinase (ERK) and mammalian target of rapamycin (mTOR) cell-signaling 
pathways in the DH (Tuscher et al., 2016).  These intriguing findings highlighted a previously 
unexplored interaction between the DH and mPFC that may have important implications for 
understanding how E2 regulates memory. As such, these data led us to question what the role 
of the mPFC is during object memory formation, and whether interactions between the DH and 
mPFC are necessary for the E2-induced memory enhancements we have previously observed in 
our object memory tasks (Fernandez et al., 2008, Boulware et al., 2013, Fortress et al., 2013). 
iii 
Therefore the overall goal of the dissertation was to examine the role of the DH and mPFC in 
object memory consolidation both in the presence and absence of exogenous E2 infusions, and 
to examine how E2 regulates spine density changes in these regions, which may ultimately 
strengthen the synaptic connections involved in the formation of such memories. To this end, 
we first utilized inhibitory Designer Receptors Exclusively Activated by Designer Drugs 
(DREADDs) to inactivate the DH, the mPFC, or both brain regions simultaneously immediately 
after novel object training to assess the role of each of these regions individually and in 
combination during object memory consolidation.   Next, we asked whether E2 can act directly 
in the mPFC to enhance object memory consolidation and increase spine density in the mPFC 
and DH.  Finally, we combined DREADD-mediated inhibition of the mPFC with direct infusion of 
E2 into the DH to examine whether DH-mPFC interactions are necessary for the beneficial 
mnemonic effects of DH infused E2.   Our results collectively suggest that individual and 
simultaneous activation of both the DH and mPFC is required for the successful consolidation of 
object recognition and spatial memories.  We also found that infusion of E2 directly into the 
mPFC increases mPFC apical spine density and facilitates object memory consolidation.  Finally, 
we demonstrate that activation of the mPFC is necessary for the memory-enhancing effects of 
DH-infused E2.  Together, these studies provide critical insight into how the DH and mPFC work 
in concert to facilitate E2-mediated memory enhancement in female mice.  Further, this work 
will enable future studies investigating circuit and cellular-level questions regarding how E2 
mediates cognition across the lifespan. 
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CHAPTER ONE: Introduction and Background Information 
 
The role of the hippocampus and prefrontal cortex in memory 
 Perhaps one of the most well-known historical examples for the role of temporal lobe 
structures, such as the hippocampus, in memory comes from observations of memory loss in 
Henry Molaison, more commonly known as patient H.M. In 1953, H.M. underwent a surgical 
procedure to reduce the frequency and severity of the debilitating seizures from which he often 
suffered (Squire, 2009).  His neurosurgeon, William Scoville, bilaterally removed a sizable 
portion of tissue from his medial temporal lobes, including his hippocampus.  Although the 
surgery did reduce his seizure activity, H.M. experienced profound anterograde memory 
impairment, as well as some retrograde memory loss (Schmolck et al., 2002).  Several 
observations of H.M.’s abilities post-surgery provided critical insight into the existence of 
different types of memory, which are distributed across several brain regions.  For example, 
despite his severe anterograde memory impairment, his skill retention for certain motor tasks 
(i.e., mirror-drawing) improved across days, even though he had no memory of previously 
attempting the task.  His intact ability to remember facts and recall remote memories from 
early in life and childhood, suggested that the medial temporal structures removed were likely 
critical for consolidation of memory, but were not the final repository for long-term memories 
(Squire and Wixted, 2011). Overall, the observations gave rise to a theory positing two larger 
classes of memory: declarative and non-declarative.  Declarative memory includes conscious 
knowledge of events (episodic memory) and facts (semantic memory).  What we now call 
declarative memory was largely impaired in H.M., and as such, the involvement of medial 
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temporal structures removed during his surgery has been the focus of most research on 
declarative memory.  However, his non-declarative memory—which includes skill and habit 
learning, simple conditioning, priming, and perceptual learning—was largely spared.  The 
contrast between H.M.’s loss of certain types of memory, but not others, formed the basis of 
our current understanding of memory systems, and supported the notion that different types 
of memory might be stored in different neural networks.  Thus, early observations of patient 
H.M. created a foundation for future investigations into the structures that subserve different 
memory systems, and ushered a new era of systems-level experimental research in clinical and 
preclinical models. 
 Since the initial insights provided by H.M. a half century ago, a great deal of information 
has been gleaned from studying the neural circuitry that supports our memory systems, 
including the prefrontal cortex, amygdala, and hippocampal region.  The “hippocampal region” 
is defined here to include CA fields, subiculum, and dentate gyrus (see Fig. 1; (Squire, 2008; 
Squire and Wixted, 2011).  Three primary pathways are utilized to transfer information into and 
throughout the hippocampus.  Information first enters from the entorhinal cortex and is 
directed to granule cells in the dentate gyrus via the perforant pathway.  Granule cells in the 
dentate gyrus then relay information through the mossy fiber pathway to the pyramidal cells of 
CA3. Next, information travels from the CA3 subfield to the CA1 subfield via the Schaffer 
collateral pathway (Squire, 2008).    Finally, information flows out of the hippocampus through 
the adjacent subiculum.  The hippocampal formation and adjacent parahippocampal regions 
are largely conserved in terms of anatomical and circuit connectivity across most mammalian 
species (Manns and Eichenbaum, 2006).  Together, these structures collaborate and operate in 
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parallel to support numerous cognitive functions, including the formation and storage of 
memories.   
 
 
 
 
 
 
 
 
 
 
 
 
 
In addition to the subiculum, the hippocampus also projects directly and indirectly to 
the medial prefrontal cortex (mPFC; Jay and Witter, 1991; Burwell and Amaral, 1998; Hoover 
and Vertes, 2007; Vertes et al., 2007), and these DH-mPFC connections will be discussed in 
greater detail in the following section (Potential interactions between the hippocampus and 
mPFC).  Evidence suggests that the mPFC, which is composed of functionally distinct regions 
along its dorsal-ventral gradient, may also contribute to long-term memory formation.  The 
functional distinctions within the mPFC likely arise due to unique afferent and efferent 
   Figure 1 
 
Figure 1. Overview of the medial temporal lobe memory system for declarative memory, which 
includes the hippocampus and the perirhinal, entorhinal, and parahippocampal cortices. (a) Schematic 
of the medial temporal lobe memory system. (b) Ventral view of a human brain (upper left), monkey 
brain (upper right), and a sagittal view of a rat brain (lower center). In humans, the hippocampus lies 
beneath the cortex of the medial temporal lobe. Its anterior region lies below the posterior entorhinal 
(shown in red) and perirhinal (shown in purple) cortices, and the main body of the hippocampus lies 
beneath the parahippocampal cortex. The parahippocampal cortex is also known as the postrhinal 
cortex in the rat brain. Abbreviations: EC, entorhinal cortex; PH, parahippocampal cortex (shown in 
brown); Por, postrhinal cortex; PR, perirhinal cortex.  Figure from Squire and Wixted, 2011. 
 
 
Figure 2.
(a) Schematic view of the medial temporal lobe memory system for declarative memory,
which is composed of the hippocampus and the perirhinal, ntorhinal, and parahippocampal
cortices. In addition to the connections shown here, there are also weak projections from the
perirhinal and parahippocampal cortices to the CA1-subiculum border. ( b) Ventral view of a
human brain (upper left), monkey brain (upper right), and a lateral view of a rat brain ( lower
center). The major cortical components of the medial temporal lobe are highlighted and
outlined. The hippocampus is not visible from the surface and in he uman lies beneath t e
cortex of the medial temporal lobe. Its anterior extent lies below the posterior entorhinal
(red ) and perirhinal ( purple) cortices, and the main body of the hippocampus lies beneath
the parahippocampal cortex. In the rat, the parahippocampal cortex is termed postrhinal
cortex. Abbreviations: EC, entorhinal cortex; PH, parahippocampal cortex ( dark yellow);
Por, postrhinal cortex; PR, perirhinal cortex.
Squire and Wixted Page 28
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which is composed of the hippocampus and the perirhinal, entorhinal, and parahippocampal
cortices. In addition to the connections shown here, there are also weak projections from the
perirhinal and parahippocampal cortices to the CA1-subiculum border. (b) Ventral view of a
human brain (upper left), monkey brain (upper right), and a lateral view of a rat brain (lower
center). The major cortical components of the medial temporal lobe are highlighted and
outlined. The hippocampus is not visible from the surface and in the human lies beneath the
cortex of the medial temporal lobe. Its anterior extent lies below the posterior entorhinal
(red ) and perirhinal ( purple) cortices, and the main body of the hippocampus lies beneath
the parahippocampal cortex. In the rat, the parahippocampal cortex is termed postrhinal
cortex. Abbreviations: EC, entorhinal cortex; PH, parahippocampal cortex (dark yellow);
Por, postrhinal cortex; PR, perirhinal cortex.
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projections to the dorsal vs. ventral subregions of this structure.   For example, ventral mPFC 
has reciprocal projections with regions involved in adaptive responses to stress or reward, such 
as the amygdala, striatum, dorsal raphe, ventral tegmental area, and locus coeruleus (Schultz, 
2001; Maier and Watkins, 2005; Itoi and Sugimoto, 2010; Kranz et al., 2010).  The ventral mPFC 
also coordinates with the hypothalamus, which regulates homeostatic drives (i.e., hunger, 
thirst), the endocrine system, and autonomic responses (Gabbott et al., 2005).  Therefore, the 
ventral mPFC is thought to be essential for regulation of autonomic and emotional control.  The 
dorsal mPFC however, has greater connectivity to regions that guide motor function (Gabbott 
et al., 2005; Hoover and Vertes, 2007) and projects directly to the spinal cord.  As such, the 
dorsal mPFC is thought to be more involved in control of actions.  Together, the unique pattern 
of connectivity for the dorsal and ventral portions of the mPFC suggest this region is poised to 
receive information sent to the ventral mPFC about rewarding or aversive stimuli within a 
particular context, which then guides adaptive behavioral responses coordinated by the dorsal 
mPFC.  The mPFC may then interact with the hippocampus to store and retrieve this 
information as necessary to guide behavioral responses that are advantageous to the organism 
during future events based on previous experience.  Chapter two of this dissertation will focus 
on the role of the mPFC, as well as its interactions with the dorsal hippocampus (DH), in the 
formation of object memories. 
 
Potential interactions between the hippocampus and mPFC 
How might the hippocampus and mPFC interact to facilitate memory formation?  A 
growing body of evidence supports the existence of direct projections from the DH to the mPFC 
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(Hoover and Vertes, 2007; Xu and Sudhof, 2023; DeNardo et al., 2015; Ye et al., 2017).  
Alternatively, there are also data indicating indirect reciprocal connections exist between the 
DH and mPFC routed through the nucleus reunions of the thalamus or lateral entorhinal cortex 
(Burwell and Amaral, 1998; Hoover and Vertes, 2007; Vertes et al., 2007).  Other anatomical 
studies examining connectivity between these regions have reported unilateral projections 
between the ventral hippocampus (VH) and subiculum of the hippocampus to the mPFC (Ferino 
et al., 1987; Jay et al., 1989; Jay and Witter, 1991; Cenquizca and Swanson, 2007).  Evidence for 
the functional relevance of these connections is supported by electrophysiological studies 
demonstrating that tetanic stimulation in the ventral CA1/subiculum of anesthetized rats 
results in stable long-term potentiation (LTP) in prefrontal neurons (Laroche et al., 1990; Jay et 
al., 1992).  Further, LTP between hippocampal and prefrontal synapses leads to a persistent 
(several day) increase in synaptic strength in awake behaving rats (Jay et al., 1996), suggesting 
direct excitatory input from the hippocampus to the mPFC.  
Behavioral studies aimed at addressing the functional relevance of prefrontal-
hippocampal interactions involve disrupting unilateral projections between the hippocampus 
and mPFC by lesioning the mPFC in one hemisphere and the hippocampus in the contralateral 
hemisphere.  These functional disconnections reportedly impair memory in rodents in the 
water maze (Wang and Cai, 2008), T-maze (Wang and Cai, 2006), and spatial win shift radial 
arm maze (Floresco et al., 1997; Goto and Grace, 2008).  Other lesion studies in which the 
hippocampus was disconnected from the mPFC have demonstrated impaired performance in 
episodic-like memory tasks, such as the object-in-place recognition memory task and temporal 
order memory task (Barker et al., 2011).  However, the same functional disconnection lesion 
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that impaired memory in the object-in-place and temporal order memory tasks failed to impair 
object location and object recognition memory (Barker et al., 2011).  Taken together, these 
findings suggest that the DH and mPFC may interact directly to mediate the formation of 
memory in some episodic memory tasks, but not others.  For example, perhaps more complex 
processing of object information in conjunction with spatial information, or object information 
in conjunction with temporal information, requires a more direct collaborative effort between 
DH and mPFC.  Alternatively, these findings may suggest that a single lesion targeting the 
unilateral projections between the hippocampus and mPFC is not sufficient to disrupt memory 
in all episodic-like tasks, as the brain may be able to compensate by utilizing indirect projections 
routed through the nucleus reunions, perirhinal or entorhinal cortices (Burwell and Amaral, 
1998; Hoover and Vertes, 2007; Vertes et al., 2007).  Further, temporary inactivation of these 
structures (i.e., pharmacological, chemogenetic or optogenetic inhibition) may yield different 
behavioral results than permanent disruption (i.e., lesions), which would likely also influence 
initial learning and memory acquisition.  Chapter 2 of this dissertation will discuss whether 
temporary inactivation of the DH alone, mPFC alone, or simultaneous inactivation of both these 
structures is sufficient to impair object memory consolidation in female mice.  Chapter 3 will 
then expand on these issues to examine the necessity of prefrontal-hippocampal interactions in 
the estrogenic regulation of memory.   
A great deal of research has been dedicated to understanding how external (i.e., 
behavioral experiences, lesions, pharmacological or genetic manipulations) or internal factors 
(i.e., changes in growth factors or hormonal milieu) influence the cognitive processes regulated 
by the hippocampus and the mPFC.  In recent years, the sex steroid hormone 17β-estradiol (E2) 
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has been shown to play an important role in mediating learning and memory.  Although our 
laboratory and others have discovered much about how E2 regulates neural plasticity and 
memory, many important questions remain.  Chief among these involve determining the 
cellular and molecular mechanisms through which E2 regulates memory formation and storage 
in the hippocampus, and how the hippocampus may interact with other brain regions such as 
the prefrontal cortex to support different types of memory.  The experiments conducted for 
this dissertation were designed to address these important issues.  To provide context to frame 
the importance of these questions, the following sections will discuss evidence supporting the 
role of E2 in learning and memory at the behavioral and molecular level. 
 
Overview of E2 across the lifespan 
 
Sex steroid hormones such as E2 are potent regulators of brain function across the 
lifespan.  They begin exerting their effects on the brain prenatally, where hormone 
concentrations differ between males and females from the first trimester of gestation (Nelson, 
2000).  This in utero exposure to estrogens guides the organization of sexually dimorphic brain 
regions involved in regulating reproductive behavior, gonadotropin secretion, and cognitive 
function in both males and females (Schwarz and McCarthy, 2008).  Neural networks 
‘organized’ during this early developmental window can then be ‘activated’ later in life by 
another surge of hormones, for example during puberty or adulthood.  In females, natural 
fluctuations in E2 levels occur across the month-long menstrual cycle in humans, and the 4-5 
day estrous cycle in rodents (Long and Evans, 1922).  Performance in mnemonic tasks and 
changes in neural plasticity have been reported to fluctuate along with these normal changes in 
endogenous hormone levels (Phillips and Sherwin, 1992; Frick and Berger-Sweeney, 2001; 
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Tuscher et al., 2014), and are also regulated by exogenous E2 treatment in ovariectomized 
female rodents (Daniel et al., 2006; Galea et al., 2008; Frick, 2009; Gibbs, 2010; Choleris et al., 
2012; Frick, 2012; Luine and Frankfurt, 2012; Maki, 2012), the latter of which will be discussed 
in greater detail below.  Finally, a precipitous loss of sex steroid hormones occurs in females 
during middle age, and a considerable amount of research has investigated how this hormone 
loss may contribute to age-related cognitive decline (Foster et al., 2003; Frick, 2009; Daniel and 
Bohacek, 2010; Rodgers et al., 2010; Smith et al., 2010) and susceptibility to neurodegenerative 
diseases, such as Alzheimer’s disease (Zandi et al., 2002; Li et al., 2012; Long et al., 2012; Li et 
al., 2014).  
E2 and hippocampal memory 
 
 The earliest work to demonstrate that the adult hippocampus is sensitive to ovarian 
hormones examined how dendritic spine density in the CA1 region of the hippocampus is 
affected by hormonal fluctuations during the estrous cycle or exogenous administration of E2 
and progesterone (P4). This work, published in the early 1990s by Bruce McEwen and 
colleagues, showed that dendritic spine density was 30% higher in the hippocampus during 
proestrus when E2 levels peak, relative to estrus, when E2 levels wane (Woolley et al., 1990). 
Further, bilateral removal of the ovaries significantly decreased spine synapse density relative 
to intact females, an effect that could be reversed within hours by acute E2 treatment alone or 
E2 + P4 (Gould et al., 1990).  In addition to dramatic changes in spine number, spine synapses 
were also increased during proestrus (Woolley and McEwen, 1992) and by exogenous E2 
treatment (Woolley and McEwen, 1993). In the years since, these findings have been replicated 
and expanded upon by numerous labs (Segal and Murphy, 2001; Li et al., 2004; MacLusky et al., 
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2005; Phan et al., 2011; Luine and Frankfurt, 2012; Phan et al., 2012; Phan et al., 2015; Tuscher 
et al., 2016a).  In fact, our own lab recently reported that an infusion of E2 directly into the DH 
increases spine density in CA1 30 minutes and 2 hours post-infusion (Fig. 2A-B; Tuscher et al., 
2016).  Surprisingly, we also found that DH-E2 infusion significantly increased basal spine 
density in the mPFC 2 hours after infusion (Fig. 2D-E), but not in other E2-sensitive regions such 
as the dentate gyrus or ventromedial nucleus of the hypothalamus (VMN; Fig. 2C and 2F).   
 
Figure 2: DH infusion of E2 increases spine density in CA1 and the mPFC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: DH E2 infusion increases spine density in CA1 and mPFC.  Relative to vehicle, basal (A) and 
apical (B) CA1 spine density were increased 30 min and 2 h after DH infusion of 5 μg/hemisphere E2. 
(C) E2 did not significantly alter dentate gyrus spine density at either time point. In the mPFC, basal 
spine density was significantly increased relative to vehicle 2 h after DH E2 infusion (D).  E2 did not 
significantly alter spine density on mPFC apical dendrites (E) or in the VMN (F) at either time point.  
Bars represent the mean ± SEM, *p < 0.05.  Adapted from Tuscher et al., 2016. 
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In a subsequent experiment, we found that ICV-E2 infusion also increased spine density 
in CA1 and the mPFC 2 hours later, and that these increases were blocked by a DH infusion of 
U0126 or rapamycin, which are inhibitors of the extracellular signal-regulated kinase (ERK) and 
mammalian target of rapamycin (mTOR) cell signaling pathways (Fig. 3; Tuscher et al., 2016).    
 
Fig. 3:  E2-induced increases in CA1 and mPFC spine density are blocked by ERK or mTOR 
inhibition in the DH 
 
 
 
 
 
 
Fig. 3.  E2-induced increases in CA1 and mPFC spine density are blocked by ERK or mTOR inhibition in the DH.  
Two hours after ICV E2 infusion, basal and apical spine density was significantly increased in CA1 (A, B) and mPFC 
(C, D) relative to vehicle.  These effects were blocked by DH infusion of U0126 or rapamycin.  Bars represent the 
mean ± SEM, *p < 0.05 relative to all other groups. (E) Photomicrograph of Golgi-impregnated secondary basal 
dendrites of CA1 pyramidal cells (panel A = vehicle+vehicle, panel B = E2+vehicle, panel C = E2+U0126).  Arrows 
denote spines. Under oil 63x.  Adapted from Tuscher et al., 2016. 
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These unexpected findings suggested a potential interaction between the DH and mPFC 
that may be critical for E2-mediated memory enhancements previously observed by our lab.  
These intriguing data, as well as the landmark findings described above, provide evidence that 
ovarian hormones can rapidly modify synaptic morphology, and laid the foundation for many of 
the questions addressed in this dissertation.  
In the nearly three decades since the initial demonstration that ovarian hormones 
regulate CA1 dendritic spine density, numerous studies have reported that E2 can enhance 
learning and memory in tasks that require the hippocampus (Packard and Teather, 1997; Fader 
et al., 1998; Daniel et al., 1999; Luine et al., 2003; Daniel, 2006; Daniel et al., 2006; Fernandez et 
al., 2008; Lewis et al., 2008; Walf et al., 2008; Fan et al., 2010; Zhao et al., 2010); see  Daniel et 
al., 2006 and Tuscher et al., 2014 for review), and this effect has been observed in adults of a 
variety of species, including songbirds, rodents, non-human primates, and humans (for review 
see: (Frick, 2009; Bimonte-Nelson et al., 2010; Hammond and Gibbs, 2011; Frick, 2012; Maki, 
2012; Schlinger and Remage-Healey, 2012).  For example, young ovariectomized rodents 
treated with exogenous E2 exhibit enhanced spatial memory in the object placement (OP), 
Morris water maze, radial arm maze, and T-maze tasks (Daniel et al., 1997; Fader et al., 1998; 
Luine et al., 1998; Fader et al., 1999; Bimonte et al., 2002; Bowman et al., 2002; Sandstrom and 
Williams, 2004).  E2 can also facilitate memory in a number of non-spatial tasks, as 
demonstrated in the object recognition (OR; Fernandez et al., 2008; Boulware et al., 2013; 
Fortress et al., 2013), social recognition (Phan et al., 2012), inhibitory avoidance (Singh et al., 
1994; Rhodes and Frye, 2004), fear conditioning (Chang et al., 2009; Barha et al., 2010; Milad et 
al., 2010; Zeidan et al., 2011; Lebron-Milad and Milad, 2012), and trace eyeblink conditioning 
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(Leuner et al., 2004) tasks.  Collectively, these studies provide converging evidence that E2 
treatment can benefit hippocampal memory in numerous behavioral tasks.  However, it should 
also be noted that several other factors impact the effects of E2 on memory, including dose, 
duration of treatment, age, length of ovarian hormone deprivation prior to treatment, type of 
memory being tested, timing of administration relative to testing, task difficulty, and 
reproductive history (Daniel, 2006; Acosta et al., 2009; Frick, 2009; Acosta et al., 2010; Luine, 
2014).  Nonetheless, the balance of studies supports the conclusion that E2 facilitates 
hippocampal memory.  The molecular mechanisms through which E2 exerts these beneficial 
effects will be discussed in greater detail below in a later section (“Molecular mechanisms 
through which E2 impacts memory”). 
 
E2 and prefrontal memory 
The effects of E2 within the mPFC are not as well characterized as those in the 
hippocampus, however tasks that recruit the mPFC, such as the Morris water maze (Leon et al., 
2010), radial arm maze (Maviel et al., 2004), delayed alternation (Wang and Cai, 2006; Izaki et 
al., 2008), inhibitory avoidance (Holloway and McIntyre, 2011; Zhang et al., 2011), fear 
conditioning (Runyan et al., 2004; Zhao et al., 2005; Corcoran and Quirk, 2007), and extinction 
of drug-associated memories (Peters et al., 2008; LaLumiere et al., 2010) are enhanced by 
systemic E2 administration (Luine and Rodriguez, 1994; Singh et al., 1994; Daniel et al., 1997; 
Packard, 1998; Rhodes and Frye, 2004; Zeidan et al., 2011; Twining et al., 2013).  Although the 
systemic route of administration cannot lead to definitive conclusions about E2 acting directly 
within the mPFC, electron microscopy has revealed that estrogen receptors (e.g., ERα, ERβ, G 
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Protein-Coupled Estrogen Receptor; GPER) are expressed throughout the mPFC (Almey et al., 
2014). This expression provides a potential mechanism of action through which E2 could bind 
and initiate cell-signaling cascades within the mPFC (i.e., ERK and mTOR) that are known to be 
essential for memory (Atkins et al., 1998; Blum et al., 1999; Fernandez et al., 2008; Hoeffer and 
Klann, 2010; Fortress et al., 2013).  Systemic E2 also enhances memory in object-based memory 
tasks (see  Luine, 2015 and Tuscher et al., 2014 for review), which some studies suggest 
requires the involvement of the mPFC (Akirav and Maroun, 2006; Warburton and Brown, 2010, 
2015).  Studies delivering systemic E2 immediately after object training have reported 
concomitant increases in mPFC spine density within 30 min after injection (Inagaki et al., 2012; 
Luine, 2015), which suggests that changes in prefrontal spine density may contribute to E2-
mediated memory enhancement in these tasks.  Additional support for this notion comes from 
our recently reported observation that DH-infusion of E2, which enhances object memory 
consolidation, also leads to an increase in spine density in the mPFC (Tuscher et al., 2016).  
However, whether these increases in mPFC spine density contribute to the memory-enhancing 
effects of DH-E2 infusion remains unknown.  Few studies have infused E2 directly into the mPFC 
to assess E2-mediated changes in memory. However, at least one study has shown that E2 
infusion into the mPFC rapidly biases female rats to use a place rather than a response strategy 
in a modified plus maze task, demonstrating that E2 can act directly within the mPFC to alter 
performance in mnemonic tasks (Almey et al., 2014).  Similarly, one other study demonstrated 
E2infusion into the mPFC improved spatial working memory in the win shift task (Sinopoli et al., 
2006).  Nevertheless, no one to date has examined whether E2 acts directly within the mPFC to 
enhance object memory formation, or whether activation of the mPFC is necessary for E2 
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infused into the DH to enhance object memories.  Chapter 3 of this dissertation will discuss 
experiments conducted to address both of these questions. 
 
Molecular mechanisms through which E2 impacts memory 
Classical estrogen receptors and genomic mechanism of action 
There are two isoforms of the classical intracellular estrogen receptors (ERs), ERα and 
ERβ, which are found within the cytoplasm and nucleus of the cell.  Localization of ERα, which 
was the first isoform characterized, dates back to the 1960s, when radioactively labeled E2 was 
used to detect it’s presence within cell nuclei of a variety of rat tissues (Jensen, 1962b).  The 
original mapping of ERα focused on its distribution in the uterus, mammary glands, pituitary 
glands, and brain, but later investigations examined expression in specific brain regions 
(McEwen, 2001), which will be described in greater detail below.  It was not until several 
decades later that ERβ, an ER with a distinct but similar binding affinity to ERα, was discovered 
in rat uterus (Kuiper et al., 1997).  ERα and ERβ have similar ligand-binding domains and affinity 
for E2, but regulate different gene targets in a tissue and cell-specific manner (Tee et al., 2004).  
Outside of the central nervous system, both ERα and ERβ are highly expressed in the ovaries, 
testes, and uterus, although each receptor has its own unique pattern of distribution.  For 
example, ERα is expressed at moderate to high levels in the pituitary, kidney, epididymis, and 
adrenals, whereas ERβ is more highly expressed in prostate, lung, and bladder (McEwen, 2001).   
Within the central nervous system, many of the brain regions that support memory 
formation and storage also express these classical intracellular ERs.  Both ERα and ERβ have 
their own distinct patterns of expression in the cerebral cortex, basal forebrain, amygdala, 
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prefrontal cortex and hippocampus in a variety of species, including mouse, rat, non-human 
primates, and humans (Shughrue et al., 1997; Osterlund et al., 2000; Shughrue and 
Merchenthaler, 2000; Shughrue et al., 2000; Milner et al., 2001; Milner et al., 2005).  In the 
basal forebrain, which sends cholinergic projections to the hippocampus and neocortex, both 
ERα and ERβ are expressed, although ERα is more abundant (Shughrue et al., 2000).  ERα and 
ERβ are also both expressed in the dorsal and ventral hippocampus, predominantly in 
pyramidal neurons of the CA1 and CA3 subfields, although ERβ is more prevalent than ERα in 
these subfields (Shughrue and Merchenthaler, 2000).  Studies examining the ultrastructural 
localization of ERs within neurons indicate the presence of ERα in the nuclei and cytoplasm of 
GABAergic interneurons, and in the cytoplasm of pyramidal and granule cells (Milner et al., 
2001).  Both receptors are found in dendritic spines and axon terminals of pyramidal neurons, 
however ERβ is more prevalent at these extranuclear sites (Milner et al., 2001; Milner et al., 
2005).  In addition, both ERs are also expressed in extranuclear sites (i.e., axons, terminals, 
dendritic shafts, and spines) in the rat mPFC (Almey et al., 2014), which receives direct and 
indirect projections from the DH (Hoover and Vertes, 2007; Burwell and Amaral, 1998;  Agster 
and Burwell, 2009; Ye et al., 2017).  
Classical intracellular hormone receptors, such as ERα and ERβ, are located within the 
cytosol and consist of 3 essential domains: the C- terminal (the site for hormone binding), the 
central domain (which binds DNA), and the N-terminal (which interacts with DNA binding 
proteins to affect transcription activation) (Nelson, 2000).  The classical “genomic” action of E2 
is initiated once the hormone dissociates from a carrier protein at the site of its target tissue, 
diffuses through the target cell’s outer membrane, and binds ERα or ERβ within the cytoplasm 
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(Nelson, 2000). Once the estrogen-receptor complex is formed, it translocates to the nucleus, 
where it binds to estrogen response elements on the DNA.  Here, the complex acts as a 
transcription factor, and can initiate the transcription of E2-sensitive genes that help maintain 
the neural circuitry that ultimately influences behavior and cognition (Jensen, 1962a; Heldring 
et al., 2007).  Changes in gene expression elicited by such nuclear receptor-hormone 
interactions, occur slowly (on the scale of hours - days), and are thought to yield long lasting 
changes.   
  
Membrane ERs and rapid cell-signaling mechanisms 
E2 can also influence cell function in a non-classical manner, by binding to membrane-
associated estrogen receptors (mERs; e.g., GPER, Gq-mER;(Srivastava and Evans, 2013), or by 
interacting with neurotransmitter receptors near the cell membrane (e.g., mGluRs, NMDARs; 
(Boulware et al., 2005; Lewis et al., 2008; Boulware et al., 2013; Smith et al., 2009), to rapidly 
activate intracellular signaling pathways on the order of seconds to minutes (Gillies and 
McArthur, 2010).  Although these mechanisms are often referred to as “non-genomic”, this 
designation should be thought of as way to distinguish a separate mode of action of 
membrane-associated ERs from classical nuclear receptor activation, and should not be taken 
literally, as activation of mERs can ultimately influence gene transcription.  For example, E2-
induced activation of membrane receptors rapidly initiates cell-signaling cascades like ERK and 
PI3K (Fernandez et al., 2008; Fan et al., 2010), whose downstream effects result in activation of 
transcription factors like CREB (Wade and Dorsa, 2003; Boulware et al., 2005).  Rapid activation 
of cell-signaling cascades such as ERK also induce post-translational epigenetic modifications 
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such as histone acetylation and DNA methylation (Zhao et al., 2010), and initiate mTOR-
mediated protein synthesis and spinogenesis (Fortress et al., 2013; Tuscher et al., 2016a). 
Therefore, binding of these non-classical receptors can still ultimately result in modified 
expression of genes important for neural plasticity and cognition.   
Studies investigating the rapid cell-signaling mechanisms initiated by E2 have focused 
primarily on their actions within the DH.  Relatively few studies have investigated the 
mnemonic effects of E2 in the mPFC, and even fewer have examined whether this region might 
collaborate with the DH to enhance the consolidation of object memories. This relatively novel 
area of neuroendocrinology research was the focus of this dissertation, and data collected to 
address each of these issues will be described in greater detail in Chapters 2 and 3.   
 
DREADDS: Using a chemogenetic approach to examine prefrontal-hippocampal interactions in 
the E2-mediated enhancement of object memory formation 
The chemogenetic approach known as DREADDs (Designer Receptors Exclusively 
Activated by Designer Drugs) was used in several experiments described in this dissertation to 
inactivate the DH, the mPFC, or both structures to examine their roles in object memory 
formation.  This technique utilizes an adeno-associated virus (Saavedra et al.) host to deliver a 
mutated human G-coupled muscarinic (e.g., hM4, hM3) receptor into neurons, which can lead 
to net suppression of neuronal firing (hM4Di), or induce burst neuronal firing (hM3Dq; Fig. 4) 
(Armbruster et al., 2007).  Point mutations in the muscarinic receptor prevent binding of its 
normal endogenous ligand, acetylcholine.  Although originally thought to be activated 
exclusively by the designer synthetic ligand clozapine-N-oxide (CNO), recent evidence has 
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emerged indicating that DREADD receptors are instead activated by clozapine, which is rapidly 
metabolized from CNO in vivo (Gomez et al., 2017). Once bound by clozapine converted CNO, 
the hM4Di receptors inhibit intracellular adenylate cyclase signaling, and activate G-coupled 
inward rectifying K+ (GIRK) channels to hyperpolarize the cell, resulting in net suppression of 
excitatory 
neurotransmission 
(Farrell and Roth, 2013).  
Conversely, hM3Dq 
receptors increase Ca2+ 
influx, leading to 
depolarization and, thus, 
an increase in neuronal 
firing (Farrell and Roth, 
2013).  In addition to 
mutated muscarinic 
DREADD receptors, a new 
Gi-coupled Kappa-opioid 
receptor DREADD (KORD) 
has recently been developed to allow for multiplexing of behavior.  Similar to muscarinic-based 
DREADDs, the modified inhibitory KORD receptor is no longer activated by its natural 
endogenous ligand (i.e., opioids), and is instead exclusively activated by the synthetic ligand 
salvinorin B (SALB; Fig. 4).  SALB is posited to be otherwise pharmacologically inert, and does 
 
Figure 4. 
 
Designer Receptors Exclusively Activated by Designer Drugs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4: General overview of DREADD- and KORD-mediated effects on 
neuronal activity.  Clozapine-N-oxide can act on either the mutated Gq-
coupled M3 receptor (hM3Dq) to induce burst firing in neurons, or the 
Gi-coupled M4 receptor (hM4Di) to suppress neuronal firing.  Ligand 
Salvinorin B binds the Kappa-opiod receptor DREADD (KORD), which 
also inhibits neuronal activity. 
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not act on other endogenously expressed receptors (Vardy et al., 2015).  Thus, SALB-activated 
DREADDs can be paired with CNO-activated DREADDs to bidirectionally modulate behavior in 
the same animal, or discretely manipulate different structures within a circuit in the same 
animal at different points in time.   Experiments described in the following chapters utilized 
both CNO- and SALB-activated DREADDs to investigate the role of the DH, the mPFC, and their 
interactions during E2-mediated enhancement of object memory formation.  The specific details 
of the experimental designs used to address these questions will be outlined in the methods 
section of each chapter. 
 
Summary and significance 
E2 is an essential modulator of cognitive function across the lifespan.  It exerts numerous 
beneficial effects on brain regions that regulate learning and memory, including the prefrontal 
cortex and hippocampus.  Despite decades of neuroendocrinology research on E2’s beneficial 
mnemonic effects, many important questions remain.  The overall goal of this dissertation was 
to gain a better understanding of the role of the DH and mPFC in the formation of object 
memory consolidation both in the presence and absence of exogenous E2 infusions, and to 
examine how E2 regulates spine density changes in these regions, which may ultimately 
strengthen the synaptic connections involved in the formation and storage of such memories. 
The DH and mPFC were the focus of this research because these brain regions are critical for 
many types of learning and memory, their function is modulated by E2, and these regions 
deteriorate significantly in aging and AD.  First, we utilized a chemogenetic approach to 
examine the necessity of the DH, the mPFC, and potential DH-mPFC interactions during object 
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memory formation in female mice.  We posited that disruption of neural activity in either brain 
region alone, or both of these regions in unison, would impair object memory consolidation.  
The experimental approach, methods, and results for this series of experiments will be 
discussed in Chapter 2.  In Chapter 3, we asked whether E2 can act directly in the mPFC to 
enhance object memory formation and increase spine density, and whether DH-mPFC 
interactions are necessary for the memory-enhancing effects of E2 infused into the DH.  We 
hypothesized that E2 would act directly in the mPFC to enhance memory consolidation and 
increase spine density in the mPFC, and that mPFC activation would be necessary for the 
memory-enhancing effects of E2 infused into the DH.    Our results suggest that both the DH and 
mPFC, as well as simultaneous activation of these brain regions, is necessary for the successful 
consolidation of object recognition and spatial memories.  We also found that infusion of E2 
directly into the mPFC increases mPFC apical spine density and facilitates object memory 
consolidation.  Finally, we demonstrate that activation of the mPFC is necessary for the 
memory-enhancing effects of DH-infused E2.   Together, the experiments described herein 
provide much needed insight into the role of the mPFC and it’s interactions with the DH during 
E2-mediated memory enhancement in females.  Further, this work will enable subsequent 
studies investigating the molecular mechanisms through which E2 mediates cognition in these 
brain regions across the female lifespan.   
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CHAPTER TWO: The role of the dorsal hippocampus, medial prefrontal cortex, and 
their interactions in object recognition memory formation 
 
INTRODUCTION 
Memory formation for a particular event or episode involves the integration of 
information regarding what was encountered, when it happened, and where the encounter 
occurred.  The acquisition of such information for episodic memories, as well as the successful 
consolidation of, and subsequent ability to retrieve, this information requires coordinated 
effort between the hippocampus and prefrontal cortex.  In humans, episodic memory is 
impaired during the course of normal aging (Shing et al., 2010; Tulving et al., 1983), in certain 
neurodegenerative disorders such as AD and PD (Dubois et al., 2007; Williams-Gray et al., 
2006), and in psychiatric disorders such as depression and PTSD (Dere et al., 2010; Kleim and 
Ehlers, 2008; McNally 2006; Williams et al., 2007; Moore and Zoellner, 2007).  Given the 
substantial public health implications of these disorders and limited therapeutic options 
currently available, it is of great interest and relevance to define the neurobiological basis of 
episodic memory formation.  Mechanistic approaches for studying episodic memory are not 
feasible in humans, therefore rodents provide a useful model for studying the functional 
connectivity and subcellular properties of the neuronal populations that support memory 
formation. 
Numerous species, including rodents, can encode and store episodic-like memories. 
Increasingly, object recognition (OR) and object placement (OP) tasks have been used to model 
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what (i.e., an object) and where (i.e., context or location within the behavioral arena) 
components of memory in rodents (Eichenbaum, 2017; Barker et al., 2017, Ennaceur, 2010; 
Dere et al., 2005; Ennaceur and Delacour, 1988).  As such, OR and OP are useful behavioral 
approaches for identifying the functional circuitry that supports episodic memory formation, as 
well as the cellular and molecular processes within each structure that subserve the circuit.  
Further, these behavioral tasks allow for the measurement of multiple types of memory 
without the confounds inherent to behavioral paradigms that involve appetitively or aversely 
motivating stimuli (McGaugh, 1989).   
Interactions between the hippocampus and medial prefrontal cortex (mPFC) have been 
implicated in episodic-like memory (Warburton and Brown, 2015) and delayed spatial working 
memory (Churchwell and Kesner, 2011) tasks, but the specific role of mPFC alone, and its 
interactions with the dorsal portion of the hippocampus during OR and OP memory formation 
remains controversial.  For example, some data suggest that mPFC activation is required for 
spatial object tasks, such as OP, but not for OR or temporal order object tasks (DeVito and 
Eichenbaum, 2010).  Yet others have reported that mPFC inactivation after object training does 
impair OR memory consolidation (Akirav and Maroun, 2006).  Behavioral studies aimed at 
addressing the functional relevance of prefrontal-hippocampal interactions often involve a 
“functional disconnection” approach, which uses lesions in the mPFC and hippocampus to 
disrupt either ispi- or contralateral projections between the two structures (Barker et al., 2017; 
Barker and Warburton, 2011, Floresco et al., 1997; Wang and Cai, 2008).  One study using this 
functional disconnection approach reported impaired performance in certain episodic-like 
memory tasks, such as the object-in-place recognition memory task and the temporal order 
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memory task, but not in object location and object recognition tasks (Barker et al., 2011). These 
findings suggest that a single lesion targeting the unilateral projections between the 
hippocampus and mPFC may not be sufficient to disrupt memory in all episodic-like tasks, as 
the brain may be able to compensate by utilizing indirect projections routed through the 
nucleus reunions or entorhinal cortex to maintain hippocampal-prefrontal communication 
(Burwell and Amaral, 1998; Hoover and Vertes, 2007; Vertes et al., 2007).  Further, temporary 
inactivation of these structures (i.e., pharmacological or chemogenetic inhibition) may yield 
different behavioral results than permanent disruption (i.e., lesions).   
In the present study, we utilized the chemogenetic approach known as DREADDs 
(Designer Receptors Exclusively Activated by Designer Drugs) to examine whether temporary 
inactivation of the dorsal hippocampus (DH) alone, mPFC alone, or simultaneous inactivation of 
both these structures disrupts episodic memory formation in female mice.  This technique 
utilizes an adeno-associated virus (Saavedra et al.) host to deliver a mutated human Gi-coupled 
muscarinic receptor (hM4-DREADD; hM4Di) or kappa opioid receptor (KOR-DREADD; KORD) 
into neurons, which leads to net suppression of neuronal firing once these receptors are bound 
by their respective synthetic ligands (e.g., clozapine-n-oxide, CNO; salvinorin-B, SALB; 
Armbruster et al., 2007; Vardy et al., 2015). We report that hM4Di-mediated inhibition of the 
DH before or immediately after training impairs spatial, but not object recognition, memory.  In 
a subsequent experiment, we utilized a multiplexed approach with hM4Di injected into the 
mPFC and KORD injected into the DH.  We found that hM4Di-mediated inhibition of the mPFC, 
or KORD-mediated inhibition of the DH, were each sufficient to impair spatial and object 
recognition memory.  Finally, we found that simultaneous subthreshold suppression of neural 
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activity in both the mPFC and DH was sufficient to disrupt object memory formation, suggesting 
that both regions coordinate to regulate OR and OP memory consolidation.  These findings 
provide new insight into the neural circuitry that supports episodic memory formation, a type 
of memory whose function is compromised during aging and in numerous neuropsychiatric 
diseases. 
 
MATERIALS AND METHODS 
Subjects. Our previous work in ovariectomized female mice demonstrated that a bilateral 
dorsal hippocampal infusion of a memory-enhancing dose of 17-estradiol increases dendritic 
spine density in both the DH and mPFC (Tuscher et al., 2016), suggesting potentially important 
interactions between the DH and mPFC in mediating memory consolidation. To maintain 
consistency with our previous work, all experiments used young (9-12 week-old) female 
C57BL/6 mice (Taconic, Cambridge City, IN) who were ovariectomized as described previously 
(Tuscher et al., 2016; Kim et al., 2016). Mice were housed in groups of up to 5 until surgery, 
after which they were singly housed.  Mice were maintained on a 12 h light/dark cycle with ad 
libitum access to food and water. All experimental protocols and procedures were approved by 
the University of Wisconsin-Milwaukee Institutional Animal Care and Use Committee and are in 
accordance with National Institutes of Health guidelines or Guide for the Care and use of 
Laboratory Animals.  
Surgery 
General. Surgeries were conducted at least 3 weeks prior to behavioral testing.    Mice were 
anesthetized with isoflurane (5% for induction, 2% for maintenance) in 100% oxygen and placed 
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in a stereotaxic apparatus (Kopf Instruments, Tujunga, CA). Female mice were ovariectomized 
and injected with virus during the same surgical session.  
 
DH DREADD surgeries.   Following ovariectomy, an incision was made in the scalp and small 
perforations were made in the skull with a 26 ½ GA needle to create an opening for bilateral 
injection of virus into the DH using a 10-µl Hamilton syringe and metal needle (Hamilton, Reno, 
NV). For our first experiment, hM4Di virus (AAV-CamKII-HA-hM4Di-IRES-mCitrine, 2.1x1012 
particles/ml, serotype 8, UNC Vector Core, Chapel Hill, NC), eGFP control virus (AAV-CamKII-
eGFP, 2.1x1012 particles/ml, serotype 8, UNC Vector Core, Chapel Hill, NC), or saline was 
injected into the DH (-1.7 mm AP, ±1.5 mm ML, -2.3 mm DV; 1.2 µl/hemisphere).  Injection 
volume and flow rate were controlled by a syringe pump (KD Scientific, Holliston, MA).  The 
Hamilton syringe was first lowered to -2.3 mm ventral to the surface of the skull and held in 
place for two minutes to create a pocket for the first viral infusion.  Three 0.4 µl injections were 
delivered per hemisphere, one at -2.2 mm, one at –2.1 mm, and one at -1.9 mm DV.  The 
Hamilton syringe was left in place 2 minutes after each injection to allow for diffusion of the 
virus, and was then slowly retracted before the process was repeated in the contralateral 
hemisphere. Mice received carprofen MediGel one day prior to surgery, as well as a s.c. 
injection of 5 mg/kg Rimadyl at the completion of surgery.  Mice were allowed a minimum of 3 
weeks for the virus to express and for surgical recovery prior to behavioral testing.   
 
Double DREADD surgeries.   For double DREADD surgeries, 2 types of inhibitory DREADDs were 
used (e.g., hM4Di, KORD), each activated by a unique ligand, to examine the role of the mPFC, 
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the DH, and their interactions during memory formation.  For virus injections into the mPFC, 
the same hM4Di DREADD described above, eGFP control virus, or saline was injected into the 
mPFC (1.8 mm AP, ±0.3 mm ML, -2.7 mm DV).  mPFC virus injections occured at the same rate 
as described for the DH (0.4 µl/2 min), however only 0.8 µl total was delivered per hemisphere 
(two 0.4 µl injections, one at -2.7 mm DV, one at -2.4 mm DV).  These infusions targeted both 
the prelimbic and infralimbic regions of the mPFC.  In the mPFC, injections were separated by 8 
minutes to allow for diffusion of the virus.  During the same surgical session, mice were also 
bilaterally injected with an inhibitory KORD virus (AAV-CamKII-HA-KORD-IRES-mCitrine, 
2.1x1012 particles/ml, serotype 8, UNC Vector Core), eGFP control virus (as described above), or 
saline into the DH (-1.7 mm AP, ±1.5 mm ML, -2.3 mm DV; 1.2 µl/hemisphere). This viral 
construct also targets the CaMKII promoter, and similar to the hM4Di DREADD, can be used to 
effectively suppress excitatory neurotransmission (Vardy et al., 2015).  Unlike the hM4-
DREADD, the KORD-DREADD is activated by the synthetic ligand Salvinorin B (SALB), and can 
therefore be used for multiplexed modulation of behavior with CNO-activated DREADDs (Vardy 
et al., 2015).  Thus, the use of both DREADDs permits determination of whether activation of 
mPFC alone, DH alone, or both mPFC and DH simultaneously is critical for memory formation in 
the same set of mice.  Mice received carprofen MediGel 1 day prior to surgery, as well as a s.c. 
injection of 5 mg/kg Rimadyl at the completion of surgery, and were allowed a minimum of 3 
weeks for the virus to express and for surgical recovery prior to behavioral testing. 
 
Drugs and Infusions.  Stock solutions of CNO and SALB (Cayman Chemical, Ann Arbor, MI) were 
dissolved in 100% dimethyl sulfoxide (DMSO; Fisher Scientific, Pittsburgh, PA) at a 
27 
 
concentration of 100 mg/ml, and stored in 10 µl aliquots at -20 oC.  On the day injections were 
administered, CNO stock was thawed and diluted to a concentration of 1 or 2 mg/ml in a 
solution of sterile 0.9% saline containing 2% DMSO.  SALB stock was thawed and diluted in 
100% DMSO to a concentration of 5 or 10 mg/ml. 
 
Behavioral Testing.  Object recognition (OR) and object placement (OP) were used to measure 
object recognition and spatial memory as we have described previously (Boulware et al., 2013; 
Fortress et al., 2013; Kim, 2016).  Previous work from our laboratory (Gresack and Frick, 2006; 
Fernandez et al., 2008) and others (Luine et al., 2003; Li et al., 2004; Walf et al., 2008) has 
established that each of these tasks involves the DH (see Tuscher et al., 2015 for review). Three 
weeks after surgery, mice were handled for 1 minute/day for 3 days prior to habituation.  After 
the first day of handling, a Lego was placed in each home cage to habituate the mice to objects 
during the remaining handling days and habituation period (Fig. 5).  After 3 days of handling, 
mice were habituated to the behavioral apparatus for 2 consecutive days by allowing them to 
explore the empty white arena (60 cm x 60 cm x 47 cm) for 5 minutes/day. For the OR task (Fig. 
5A), mice are required to accumulate 30 seconds exploring 2 identical objects placed 5 cm from 
the upper left and right corners of the arena during the training phase. Mice that did not 
accumulate a total of 30 seconds exploring the objects during training were not infused or 
injected, and were not included in testing.  Either 30 minutes prior to or immediately after 
training, mice were injected i.p. with CNO, SALB, or both in two separate syringes. Pre-training 
injections were used first to examine the effects of DREADD-mediated inhibition on memory 
acquisition and consolidation.  Post-training injections were next used to pinpoint the effects of 
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Fig. 5. Overview of object memory testing protocols. Mice are first habituated to an empty arena prior to 
beginning behavioral training (habituation). (A) In object recognition (OR), mice are then allowed to explore 
two identical novel objects placed in the arena (training). Finally, retention is tested by presenting mice with 
one novel and one familiar object (testing). Mice who remember the familiar object from training spend 
more time exploring the novel object relative to the familiar object or to chance (15 sec). (B) Object 
placement (OP) uses the same apparatus and general procedure, but during testing, one training object 
moves to a new location in the arena, rather than being replaced with a new object. Mice who remember 
the object in the familiar location spend more time exploring the moved object relative to the unmoved 
object or to chance. (C) Object pairs used in our laboratory’s OR and OP protocols. 
 
DREADD-mediated inactivation specifically to the memory consolidation period, while 
minimizing potential confounding effects on performance factors (e.g., motivation, anxiety) 
during training or retention testing (McGaugh, 1989; Frick and Gresack, 2003). OR memory was 
then tested 24 hours later by measuring the amount of time spent with the novel and familiar 
object. Intact OR memory consolidation is demonstrated if the mice spend more time than 
chance (15 seconds) with the novel object during testing.  At the 24-hour time point, vehicle-
infused ovariectomized females show intact object recognition (Fortress et al., 2013, Boulware 
et al., 2013), thereby permitting observation of the potential memory-impairing effects of 
DREADD-mediated inactivation. 
 
Fig. 5: Overview of the object memory testing protocols 
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Training and testing for OP was identical to OR, except that testing was conducted 4 hours after 
training, and involved moving one of the identical training objects to a new location in the 
arena (lower right or lower left corner) during testing (Fig. 5B).  Intact spatial memory was 
demonstrated if mice spent more time than chance with the moved object.  At the 4-hour 
delay, vehicle-infused ovariectomized females show intact OP memory (Boulware et al., 2013; 
Kim et al., 2016), which allowed any DREADD-mediated spatial memory impairments to be 
observed.  All mice were trained and tested in both behavioral tasks.  To counterbalance the 
order in which behavior was completed, half of the mice completed OR first, followed by OP, 
and the other half completed OP first, followed by OR.  OR and OP training were separated by 
one week, and mice were trained with a unique set of objects for each task. 
 
Histological verification of DREADD expression.  Histology was performed to verify expression 
of hM4Di and KORD in the mPFC and DH, respectively.  Three weeks after surgery, mice 
(n=3/group) were anesthetized with isoflurane and perfused with 4% paraformaldehyde (PFA) 
in 1X PBS. Whole mouse brains were then removed and post-fixed in 1X PBS/4% PFA overnight, 
followed by dehydration in a 1X PBS/30% sucrose solution until brains sank. Tissue was then 
sectioned on a cryostat (40 µm) and free-floated in 1X PBS until mounted onto microscope 
slides (VWR, Arlington Heights, IL) using aqueous mounting medium containing the nuclear 
stain DAPI.  Fluorescent images were captured using an Olympus Fluoview FV1200 confocal 
microscope and accompanying software.    
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Data analysis.  All statistical analyses were conducted using GraphPad Prism 6 (La Jolla, CA).  To 
determine whether each group demonstrated intact memory for each behavioral task, OR and 
OP data were first analyzed using one sample t-tests to determine if the time spent with the 
novel or moved object differed significantly from chance (15 seconds; Kim et al., 2016, Fortress 
et al., 2013, Boulware et al., 2013).  This analysis was used because time spent with the objects 
is not independent; time spent with 1 object reduces time spent with the other object (Frick 
and Gresack, 2003).   Student’s t tests were then used to determine significant differences in 
performance between control and DREADD mice. Statistical significance for all analyses was 
determined as p ≤ 0.05. 
 
RESULTS 
hM4Di-mediated inhibition of the DH impairs OP but not OR memory  
Three weeks after surgery, brain tissue was collected from a subset of mice to verify 
eGFP and hM4Di expression in the DH at the initiation of behavioral testing (Fig. 6A-D).  To test 
whether hM4Di-mediated inactivation of the DH impairs OP and OR memory formation, mice 
injected with saline, eGFP, or hM4Di into the DH received 2 mg/kg of CNO i.p. 30 minutes 
before OP or OR training (Fig. 7A&B).  OP memory was tested 4 hours after training.  Because 
Sham and eGFP controls did not differ, they were combined into a single control group and 
compared to the hM4Di group. Sham and eGFP mice administered 2 mg/kg CNO 30 minutes 
prior to training spent significantly more time than chance exploring the displaced object during 
OP testing (Sham+eGFP: t(12) = 5.80, p < 0.0001; Fig. 7C), demonstrating intact spatial memory 
and suggesting that 2 mg/kg CNO is a behaviorally-ineffective subthreshold dose that does not 
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impair OP memory on its own. However, hM4Di mice did not spend significantly more time 
than chance with the displaced object (hM4Di: t(8) = 0.09, p = 0.93; Fig. 7C), suggesting that 
spatial memory was impaired by hM4Di-mediated inhibition of the DH.  Mice expressing hM4Di 
in the DH also spent significantly less time with the moved object than control mice (t(20) = 3.24, 
p = 004; Fig. 7C), providing further evidence that spatial memory was impaired by DREADD-
mediated suppression of the DH.   
OR memory was evaluated 24 hours after training.  In contrast to the OP task, Sham, 
eGFP, and hM4Di mice all spent significantly more time than chance with the novel object 
during testing (Sham+eGFP: t(10) = 4.39, p = 0.001; hM4Di: t(6) = 3.41, p < 0.01; Fig. 7D), 
suggesting that all groups had intact object recognition memory.  Together, these data suggest 
that hM4Di-mediated inhibition of the DH, as driven by 2 m/kg CNO, impairs spatial memory 
but not object recognition memory.  
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Fig. 6: hM4Di and eGFP expression in the DH 3 weeks after injection 
 
 
 
 
 
 
Fig. 6: (A&C) Coronal sections (40 µm) of CaMKIIα-hM4Di-mCitrine DREADD or (B&D) CaMKIIα-
EGFP control virus in female mouse brain 3 weeks post-injection demonstrate high levels of 
expression in the dentate gyrus, as well as weaker expression in CA1 and CA3. Blue puncta: DAPI; 
yellow: mCitrine-tagged DREADD virus; green: eGFP-tagged control virus.  
 
C) 
D) 
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Fig. 7: Pre-training hM4Di-mediated inhibition of the DH impairs OP, but not OR, memory 
 
 
 
 
 
 
Because our CNO injections were administered prior to training, it was not clear if 
DREADD-mediated inhibition of the DH impaired acquisition or consolidation of OP memory 
formation.  To target the consolidation period of memory formation, the same mice were 
trained one week later with a new set of objects in the OP task and were injected with 2 mg/kg 
CNO immediately after training (Fig. 8A) to pinpoint effects on memory consolidation.  Sham 
and eGFP control mice spent significantly more time than chance with the moved object, 
Fig. 7: Experimental design for pre-training CNO injections using the object placement (A) and object 
recognition task (B). (C) In the object placement task, DH sham and eGFP control mice administered 2 mg/kg 
CNO 30 minutes before training spent significantly more time than chance (15 s) with the moved object 4 
hours after training, whereas DH-hM4Di-expressing mice administered 2 mg/kg CNO did not. (D) In the 
object recognition task, DH Sham, eGFP, and hM4Di mice administered 2 mg/kg CNO 30 minutes prior to 
training all spent significantly more time than chance (15 s) with the novel object during testing, suggesting 
intact object recognition memory 24 hours after training. This finding suggests that hM4Di-mediated 
inactivation of the DH impairs spatial memory formation.  Bars represent the mean ± SEM, *p < 0.05.   
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demonstrating intact OP memory (Sham+eGFP: t(13) = 4.84, p = 0.0003; Fig. 8C), whereas hM4Di 
expressing mice administered 2 mg/kg CNO did not, suggesting that hM4Di-mediated 
inactivation of the DH impaired OP memory consolidation (hM4Di: t(8) = 0.08, p = 0.94; Fig. 8C).  
Sham and eGFP control mice also spent significantly more time with the moved object during 
testing than the hM4Di group (t(21) = 3.07, p = 0.006; Fig. 8C), further supporting the notion that 
DREADD-mediated inhibition of the DH disrupts spatial memory consolidation.   
To examine whether post-training hM4Di-mediated inactivation of the DH also impairs 
OR memory consolidation, we trained the same mice in the OR task with novel objects, and 
administered 2 mg/kg immediately after training (Fig. 8B).  Unlike OP, 2 mg/kg CNO did not 
impair OR memory consolidation in either group (Sham+eGFP: t(10) = 4.39, p = 0.001; hM4Di: t(6) 
= 3.41, p = 0.01; Fig. 8D).  To test if higher doses of CNO could impair OR memory consolidation 
in mice expressing hM4Di DREADDs in the DH, we also administered 4 or 8 mg/kg immediately 
after object recognition training.  Neither the 4 mg/kg (Sham+eGFP: t(9) = 2.71, p = 0.02; hM4Di: 
t(8) = 2.60, p = 0.03; Fig. 8E),  or 8 mg/kg  (Sham+eGFP: t(11) = 6.58, p < 0.0001; hM4Di: t(8) = 3.78, 
p = 0.01; Fig. 8F) dose of CNO impaired OR performance in the Sham, eGFP, or hM4Di groups. 
Collectively, these data suggest hM4Di-mediated suppression of neurotransmission in the DH is 
sufficient to impair spatial, but not object recognition, memory consolidation. 
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Fig. 8: Post-training hM4Di-mediated inhibition of the DH impairs OP, but not OR, memory 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8: (A&C) In the object placement task, DH sham and eGFP control mice administered 2 mg/kg 
CNO immediately post-training spent significantly more time than chance (15 s) with the moved 
object 4 hours after training, whereas DH-hM4Di-expressing mice administered 2 mg/kg CNO did 
not. (B) In the object recognition task, DH Sham, eGFP, and hM4Di mice administered 2 mg/kg 
(D), 4 mg/kg (E), or 8 mg/kg (F) CNO immediately post-training all spent significantly more time 
than chance (15 s) with the novel object during testing, suggesting intact object recognition 
memory 24 hours after training. This finding suggests that hM4Di-mediated inactivation of the DH 
impairs spatial memory consolidation.  Bars represent the mean ± SEM, *p < 0.05. 
 
36 
 
 
hM4Di-mediated inhibition of the mPFC impairs OP and OR memory consolidation  
  To investigate the role of the mPFC alone, and its interactions with the DH, during object 
memory consolidation, a new set of mice was injected with the hM4Di inhibitory DREADD into 
the mPFC and another Gi-coupled inhibitory DREADD (kappa opioid receptor-DREADD; KORD) 
into the DH. Unlike the hM4-DREADD, the KOR-DREADD is activated by the synthetic ligand 
salvinorin-B (SALB), and can therefore be used for multiplexed modulation of behavior with 
CNO-activated DREADDs, such as hM4Di (Vardy et al., 2015).  We used these two constructs to 
determine in the same mice whether activation of the mPFC alone, DH alone, or both mPFC and 
DH simultaneously is critical for memory formation.  This approach yielded three experimental 
groups: 1) mPFC-hM4Di + DH-KORD, 2) mPFC-eGFP + DH-eGFP, and 3) mPFC-Sham + DH-Sham.  
Expression of eGFP (Fig. 9E&G) or hM4Di in the mPFC (Fig. 9A&C) and eGFP (Fig. 9F&H) or KORD 
(Fig. 9B&D) in the DH was verified by fluorescence microscopy 3 weeks after surgery.  
Expression of mPFC-hM4Di and DH-KORD DREADDs were also detected at 6 weeks (Fig. 10A&B) 
and 18 weeks (Fig. 10C&D) post-injection.   
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Fig. 9: mPFC-hM4Di, DH-KORD, and eGFP expression 3 weeks post-injection 
 
 
 
 
 
 
 
 
 
C) 
D) 
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Fig. 9: Representative coronal sections (40 µm) of CaMKIIα-hM4Di-mCitrine DREADD in the mPFC (A&C), 
CaMKIIα-KORD-mCitrine DREADD in the DH (B&D), and CaMKIIα-eGFP control virus in the mPFC (E&G) or 
DH (F&H) in female mouse brain 3 weeks post-injection. Blue puncta: DAPI; yellow: mCitrine-tagged 
DREADD virus; green: eGFP-tagged control virus.   
 
E) F) mPFC eGFP Expression DH eGFP Expression 
G) 
H) 
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Fig. 10: mPFC-hM4Di and DH-KORD expression 6 and 18 weeks post-injection 
 
 
 
 
 
 
 
 
 
 
 
6 weeks post-injection 
A) 
B) 
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To examine if mPFC activation alone is necessary for spatial memory consolidation, mice 
were trained in OP and then received an i.p. injection of CNO immediately after training (Fig. 
11A).  Mice expressing hM4Di in the mPFC spent no more time than chance with the displaced 
object during testing 4 hours later when injected with 2 mg/kg CNO (hM4Di: t(5) = 0.40, p = 0.71; 
18 weeks post-injection 
 
 
 C) 
D) 
Fig. 10: Representative coronal sections (40 µm) of CaMKIIα-hM4Di-mCitrine DREADD in the mPFC 
(A&C) or CaMKIIα-KORD-mCitrine in the DH (B&D) in female mouse brain 6 weeks (A&B) and 18 
weeks (C&D) post-injection. Blue puncta: DAPI; yellow: mCitrine-tagged DREADD virus; green: eGFP-
tagged control virus.   
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Fig. 11C), but not 1 mg/kg, CNO (hM4Di: t(8) = 5.04, p = 0.001; Fig. 4E).  The Sham+eGFP group 
demonstrated intact spatial memory after i.p. injection of either 1 mg/kg CNO (Sham+eGFP: t(14) 
= 6.51, p < 0.0001; Fig. 11E) or 2 mg/kg CNO (Sham+eGFP: t(12) = 6.34, p < 0.0001; Fig. 11C), 
suggesting that both doses were subthreshold for controls.   Further, Sham+eGFP control mice 
and hM4Di expressing mice injected with 1 mg/kg CNO did not differ in the amount of time 
spent with the displaced object (t(22) = 0.24, p = 0.81; Fig. 11E).   These findings suggest that 
hM4Di-mediated inhibition of the mPFC impairs OP memory after administration of 2 mg/kg, 
but not 1 mg/kg, of CNO.  Mice expressing hM4Di in the mPFC also spent significantly less time 
with the displaced object during testing than control mice when injected with 2 mg/kg CNO 
(t(17) = 3.10, p = 0.006; Fig. 11C), further demonstrating DREADD-induced suppression of the 
mPFC disrupts spatial memory consolidation.   
We next examined object recognition memory consolidation, and found that 2 mg/kg of 
CNO administered immediately after OR training impaired object recognition memory 
consolidation in mice expressing hM4Di in the mPFC, as these mice did not spend more time 
than chance with the novel object during testing (hM4Di: t(8) = 0.47, p = 0.65; Fig. 11D).  In 
contrast, the Sham+eGFP group was not impaired by 2 mg/kg CNO when tested 4 hours later 
(Sham+eGFP: t(13) = 2.64, p = 0.02; Fig. 11D).  mPFC-hM4Di mice injected with 2 mg/kg CNO 
immediately post-training also tended to spend less time with the novel object during testing 
than controls (t(21) = 1.58, p = 0.12; Fig. 11D), suggesting suppression of the mPFC impaired OR 
memory.  Post-training injection of 1 mg/kg CNO did not impair OR memory consolidation in 
any treatment condition (hM4Di: t(5) = 3.32, p = 0.02; Sham+eGFP: t(12) = 4.80, p = 0.0004; Fig. 
11F), and the amount of time spent with the novel object was not statistically different 
42 
 
between Sham+eGFP control mice and hM4Di expressing mice injected with 1 mg/kg CNO (t(17) 
= 0.83, p = 0.42; Fig. 11F).  Collectively, these data suggest that suppression of mPFC 
neurotransmission by 2 mg/kg CNO disrupted both spatial and object recognition memory 
consolidation.   
Fig. 11: hM4Di-mediated inhibition of the mPFC impairs OP and OR memory consolidation  
 
 
 
 
Fig. 11: Experimental design for the object placement (A) and object recognition task (B). DREADD-mediated 
inhibition of the mPFC impaired both object placement (C) and object recognition (D) memory in mice expressing 
hM4Di in the mPFC that were administered 2 mg/kg CNO immediately after training. A 1 mg/kg dose of CNO did 
not impair memory in the object placement (E) or object recognition (F) task. This finding suggests that hM4Di-
mediated inactivation of the mPFC impairs spatial and object recognition memory consolidation.  Bars represent 
the mean ± SEM, *p < 0.05, 
#
p  0.1.   
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KORD-mediated inhibition of the DH impairs OP and OR memory consolidation 
Our first series of experiments examining hM4Di-mediated inactivation of the DH 
indicated that DH activity is necessary for OP, but not OR, memory consolidation.  However, 
numerous pharmacological studies suggest that DH activity is necessary for consolidation in 
these tasks (Baker and Kim, 2002; Broadbent et al., 2004; Hammond et al., 2004; Fernandez et 
al., 2008; Zhao et al., 2012; Cohen et al., 2013; Fortress et al., 2013), and so we examined the 
effects of KORD-mediated DH inhibition on OR and OP memory to determine if the effects 
observed with the hM4Di DREADD would generalize to another viral construct. The same mice 
described above were trained in OP and OR with new sets of objects (Fig. 12A & B).  Sham and 
eGFP mice injected immediately post-training with 10 mg/kg SALB (Sham+eGFP: t(16) = 4.10, p = 
0.001; Fig. 12C) or 5 mg/kg SALB (Sham+eGFP: t(14) = 4.77, p = 0.0003; Fig. 12E) spent 
significantly more time than chance with the moved object during testing, demonstrating that 
SALB does not impair OP memory consolidation on its own at these doses. In mice expressing 
KORDs in the DH, 10 mg/kg SALB impaired spatial memory consolidation, as these mice did not 
spend more time than chance with the displaced object during testing (KORD: t(8) = 1.35, p = 
0.21; Fig. 12C).  However, OP memory consolidation was not impaired in DH KORD-expressing 
mice by 5 mg/kg SALB (KORD: t(8) = 3.45, p = 0.01; Fig. 12E), suggesting this dose was insufficient 
to trigger KORD-mediated inactivation. Further, Sham+eGFP control mice and KORD expressing 
mice injected with 5 mg/kg SALB did not differ in the amount of time spent with the displaced 
object (t(22) = 0.69, p = 0.50; Fig. 12E).    
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As in the OP task, Sham and eGFP mice injected with 10 mg/kg SALB (Sham+eGFP: t(12) = 
2.22, p = 0.04; Fig. 12D) or 5 mg/kg SALB (Sham+eGFP: t(7) = 5.23, p = 0.001; Fig. 12F), 
demonstrated intact OR memory.  Also similar to OP, immediate post-training injection of 10 
mg/kg SALB prevented DH-KORD mice from spending more time than chance with the novel 
object during testing 24 hours later (KORD: t(8) = 1.14, p = 0.29; Fig. 12D), suggesting impaired 
object recognition memory consolidation.  Again, OR was not impaired by 5 mg/kg SALB in DH-
KORD mice (KORD: t(9) = 4.15, p = 0.002; Fig. 12F), and the amount of time spent with the novel 
object was not statistically different between Sham+eGFP control mice and KORD expressing 
mice injected with 5 mg/kg SALB (t(16) = 1.41, p = 0.18; Fig. 12F).  Collectively, these findings 
show KORD-mediated suppression of the DH impairs both OP and OR memory consolidation.  
The fact that OR memory consolidation was impaired in the DH by KORD-mediated inactivation, 
but not hM4Di-mediated inactivation, suggests potentially interesting differences in the effects 
of these viruses and/or their relative expression in these two studies. 
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Fig. 12: KORD-mediated inhibition of the DH impairs OP and OR memory  
 
 
 
 
 
 
 
 
 
 
 
Fig. 12: Experimental design for the object placement (A) and object recognition task (B). DREADD-
mediated inhibition of the DH impaired both object placement (C) and object recognition (D) memory in 
mice  expressing KORD in the DH that were administered 10 mg/kg SALB immediately after training. A 5 
mg/kg dose of SALB did not impair memory in the object placement (E) or object recognition (F) task. 
This finding suggests that KORD-mediated inactivation of the DH impairs spatial and object recognition 
memory consolidation.  Bars represent the mean ± SEM, *p < 0.05.   
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Simultaneous subthreshold inhibition of the mPFC and DH impairs OP and OR memory  
Finally, to examine the potential interaction between the DH and mPFC during object 
recognition and spatial memory consolidation, we used subthreshold doses of CNO and SALB to 
simultaneously suppress neurotransmission in the DH and mPFC. Importantly, neither dose of 
CNO (1 mg/kg; Fig.11E & F) or SALB (5 mg/kg; Fig. 12E & F) used for this experiment was 
sufficient to impair memory in either OP or OR when administered on its own.  Thus, any 
memory impairments observed should be a result of combined disruption of the DH and mPFC.  
To this end, immediately after training with a new set of objects, mice were injected i.p. with 1 
mg/kg CNO and 5 mg/kg SALB delivered in separate syringes.  We found that Sham and eGFP 
mice administered this combined subthreshold injection protocol spent more time than chance 
with the moved object in OP (Sham+eGFP: t(5) = 4.61, p = 0.006; Fig. 13C)  and the novel object 
in OR (Sham+eGFP: t(11) = 5.43, p = 0.02; Fig. 13C), suggesting spatial and object recognition 
memory was not impaired in our control groups.  However, mice expressing hM4Di in the mPFC 
and KORD in the DH spent no more than chance amount of time with the moved object during 
OP testing (mPFC-hM4Di + DH-KORD: t(8) = 1.33, p = 0.22; Fig. 13C) and the novel object during 
OR testing (mPFC-hM4Di + DH-KORD: t(8) = 0.01, p = 0.99; Fig. 13D) when injected with 1 mg/kg 
CNO and 5 mg/kg SALB immediately after training.  Further, mPFC-hM4Di + DH-KORD mice 
administered 1 mg/kg CNO and 5 mg/kg SALB post-training also spent significantly less time 
with the moved object than the Sham and eGFP control groups during OP testing (t(13) = 3.58, p 
= 0.003; Fig. 13C), and trended toward spending less time with the novel object than Sham and 
eGFP control mice in the OR task (t(19) = 1.75, p = 0.09; Fig. 13D).  These findings suggest 
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simultaneous disruption of neurotransmission in the mPFC and DH impairs spatial and object 
recognition memory consolidation. 
 
Fig. 13: Simultaneous subthreshold inhibition of the mPFC and DH impairs OP and OR 
memory  
 
 
 
 
 
 
 
 
Fig. 13: Experimental design for the object placement (A) and object recognition (B) subthreshold inactivation 
experiments. Doses of CNO and SALB that do not impair memory on their own impair OP (C) and OR (D) 
memory when administered simultaneously in mice expressing KORD in the DH and hM4Di in the mPFC.  
Subthreshold doses of SALB and CNO do not impair memory in Sham and eGFP control mice in either task.  This 
finding suggests that simultaneous neural activity in both the DH and the mPFC is necessary for the 
consolidation of spatial and object recognition memories. Bars represent the mean ± SEM, *p < 0.05, 
#
p < 0.10.   
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DISCUSSION 
The goal of the present study was to determine the roles of the mPFC and DH, 
independently and in combination, in object recognition and spatial memory consolidation.  
Using two different inhibitory DREADD constructs, we found that inhibition of either the mPFC 
or DH impaired the consolidation of both types of memory, although DH inhibition impaired 
object recognition only when using the KORD construct.  These data suggest that both the 
mPFC and DH play key roles in mediating object recognition and spatial memory consolidation.  
Importantly, these brain regions appear to work in concert to mediate memory in the OR and 
OP tasks, as simultaneous disruption of neurotransmission in both brain regions using 
subthreshold doses of DREADD ligand impaired memory consolidation in both tasks.   
Our present findings that DH inactivation can disrupt OP memory using the hM4Di 
DREADD and both OP and OR using the KORD DREADD are consistent with previously published 
evidence demonstrating that inhibiting DH function in rodents impairs performance in object 
tasks.  For example, OR memory consolidation is impaired when the hippocampus is lesioned or 
pharmacologically inhibited by GABAA agonists, NMDA antagonists, or inhibitors of ERK/MAPK 
cell signaling, histone acetylation, and protein synthesis (Baker and Kim, 2002; Broadbent et al., 
2004; Hammond et al., 2004; Fernandez et al., 2008; Zhao et al., 2012; Cohen et al., 2013; 
Fortress et al., 2013).  Given previous studies demonstrating that DH inactivation impairs OR 
memory consolidation, it is perhaps not surprising that suppression of excitatory 
neurotransmission in the DH impaired memory consolidation in both OR and OP.  However, 
despite numerous studies showing that DH activation is necessary for OR memory formation, 
some have reported that DH inactivation does not impair OR (Mumby, 2001; Winters et al., 
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2004; Forwood et al., 2005; Squire et al., 2007; Broadbent et al., 2010).  Further, others have 
reported DH infusion of hM4Di DREADDs impaired performance in the OP task, but did not 
impair OR memory in male mice (Lopez et al., 2016).  Similarly, we also found that hM4Di-
mediated inactivation of the DH was only sufficient to impair OP, but not OR, memory 
consolidation.  Although it is not entirely clear why one inhibitory DREADD impaired OR while 
another form of inhibitory DREADD driven by the same CaMKII promoter did not, there are a 
couple reasons why this might be the case. One possibility is that the proportion of neurons 
transfected by the DREADD may have differed by cohort.  Although the percentage of DREADD-
transfected cells was not quantified in each experiment to allow for direct comparison, there 
were notable differences in the pattern of DREADD expression between mice injected with 
hM4Di vs. KORD in the DH.  Namely, we observed more KORD DREADD in the hilar region of the 
dentate gyrus and in CA2 compared to the hM4Di DREADD (see Fig. 6C, 9D, 10B&D). Therefore, 
it is possible that a larger population of neurons was inhibited during the KORD-mediated 
inactivation experiment, and as such, neurotransmission was disrupted in a larger proportion of 
the DH.  Alternatively, spatial memory may be more easily disrupted by perturbations of the DH 
compared to recognition memory (Broadbent et al., 2004; Squire et al., 2007; Wilson et al., 
2013).  Thus, DREADD-mediated inactivation of the DH may be sufficient to impair spatial 
memory, whereas the entorhinal or perirhinal cortices may be able to compensate for partial 
DH disruption in recognition-based tasks.   
Our data also suggest that hM4Di-mediated inactivation of the mPFC immediately after 
training impaired both OR and OP memory consolidation.  Although at least one study has 
implicated the mPFC as a critical locus for OR and OP memory consolidation (Akirav and 
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Maroun, 2006), other mPFC inactivation studies have suggested that this region is involved in 
spatial object tasks but not OR (Warburton and Brown, 2015, DeVito and Eichenbaum, 2010).  
One potential factor that may contribute to this discrepancy is the length of the delay between 
training and testing.  In studies concluding that mPFC activation was not necessary for OR, only 
a 50 minute or 2-hour delay was imposed between training and testing (DeVito and 
Eichenbaum, 2010, Barker, 2007).  However, a study using a 24-hour delay between training 
and testing reported that mPFC inactivation impaired OR memory (Akirav and Maroun, 2006).  
Therefore, it may be that the mPFC is critical for consolidation of long-term memories (i.e., 
beyond 2 hours), but not short-term memories (i.e., less than 2 hours).  This theory is consistent 
with our present findings, which indicate that recall at 4 or 24 hours is impaired when 
neurotransmission is disrupted in the mPFC immediately after training.  
This report is the first to our knowledge using multiplexed inhibitory DREADDs to 
partially inactivate both the DH and mPFC during memory formation to address whether 
simultaneous activity in these regions is required for episodic-like memory consolidation.  Given 
the numerous potential routes of communication between the DH and mPFC (Ye et al., 2017, 
Hoover and Vertes, 2007, Burwell and Amaral, 1998, Cenquizca and Swanson, 2007), this 
approach prevented potential compensatory effects through alternate indirect routes (i.e., 
nucleus reunions, entorhinal and perirhinal cortices) which could be utilized in functional 
disconnection studies that only disrupt either ipsi- or contralateral communication between 
these structures (Warburton and Brown, 2015).  Importantly, we used doses of CNO (1 mg/kg; 
Fig. 11E & F) and SALB (5 mg/kg; Fig. 12E & F) that were not sufficient to impair object memory 
consolidation in either task when used alone to suppress neurotransmission in the mPFC or DH, 
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respectively. Although our findings cannot definitively attribute memory impairment to 
blockade of a direct, monosynaptic connection between DH and mPFC, these data do provide 
support that both regions must be functional for the successful consolidation of OR and OP 
memories.  Future studies utilizing chemogenetic or optogenetic approaches to selectively 
target DH projection terminals in the mPFC (rather than silencing the entire mPFC) could be 
used to address whether direct DH efferent input into the mPFC is necessary for episodic-like 
memory formation.  
The fact that simultaneous disruption of neurotransmission in the mPFC and DH 
impaired memory consolidation in the present experiments is consistent with other research 
reporting temporally-coordinated neuronal activity in these regions during periods of sleep and 
wakefulness in rodents is necessary for systems memory consolidation.  For example, 
hippocampal input to the mPFC during sleep or slow-wave oscillations during rest periods after 
behavioral training are required for consolidation (Schwindel and McNaughton, 2011).  During 
periods of wakefulness, neuronal firing in the DH and mPFC is phase-locked to hippocampal 
theta oscillations, and firing coherence is increased during spatial working memory tasks (Jones 
and Wilson, 2005, Hyman et al., 2005, 2010).  Further, reduced theta rhythm coherence 
between CA1 and mPFC in mice is correlated with poor performance in a spatial working 
memory task (Sigurdsson et al., 2010).  Given that hippocampal-prefrontal neural synchrony 
appears to be important for memory consolidation in the aforementioned studies, it follows 
that simultaneous chemogenetic suppression of the DH and mPFC in the present study may 
have disrupted functional connectivity between the DH and mPFC, which ultimately impaired 
OR and OP memory consolidation. 
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Our present findings also align with recent work demonstrating that direct input from 
the dentate gyrus into the mPFC during contextual fear conditioning is necessary for 
establishing immature engram cells within the mPFC (Kitamura et al., 2017).  Disruption of 
these DH-mPFC interactions during fear conditioning also prevents spine density increases later 
observed on eYFP labeled engram cells in the mPFC at a remote memory test (Kitamura et al., 
2017).  This work and our current findings support the idea that communication between the 
DH and mPFC must be established during the consolidation period in order to support long-
term memory formation.  Other recent research investigating the necessity of DH-mPFC 
interactions during memory formation has shown that DREADD-mediated inhibition of DH 
projection terminals in the  mPFC prior to reactivation sessions prevents reactivation-induced 
increases in fear memory expression and memory-associated proteins in the mPFC (e.g., Arc, 
pCREB, and pCofilin protein; (Ye et al., 2017).  Taken together, these studies and our present 
findings lend additional support to the idea that the DH and mPFC individually contribute to, 
and also work together during, the successful consolidation of episodic-like memories. 
 
SUMMARY AND CONCLUSION 
In summary, the present study indicates that both the DH and the mPFC are required for 
the consolidation of object recognition and spatial memories, as suppressing neurotransmission 
in either brain region impairs performance in each of these tasks.  In addition to the individual 
contribution of each brain region, our data also support the notion that these brain regions 
must act in concert to consolidate object recognition and spatial memories.  Collectively, these 
findings provide additional insight into the neurobiological basis of episodic-like memory 
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formation, and may provide an important foundation for studying how hippocampal-prefrontal 
communication is compromised in certain neuropsychiatric disorders.    
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CHAPTER THREE: Dorsal hippocampal and medial prefrontal interactions in the estrogenic 
regulation of object memory formation 
 
INTRODUCTION 
Sex-steroid hormones have a broad impact on the neural circuitry that supports learning 
and memory, yet much remains unknown about the cellular, synaptic, and circuit-level 
mechanisms through which they exert their effects. The potent estrogen 17β-estradiol (E2) can 
regulate neuronal excitability and spinogenesis in the dorsal hippocampus (DH) and medial 
prefrontal cortex (mPFC), brain regions important for cognitive function that are compromised 
during aging and in numerous neuropsychiatric disorders.  Memory consolidation, a process 
which requires coordinated effort between the hippocampus and mPFC, is facilitated by 
systemic injection or direct infusion of E2 into the DH of female rodents.  However, the specific 
mechanisms through which E2 enhances memory consolidation remain poorly understood, and 
little is known about how interactions between the DH and mPFC might contribute to the 
estrogenic regulation of memory.  
The object recognition (OR) and object placement (OP) tasks involve the integration of 
what and where components of memory, and are commonly used to assess episodic-like 
memory in rodents (Dere et al., 2005; Ennaceur, 2010; Barker et al., 2017; Eichenbaum, 2017).  
Our laboratory has previously demonstrated that direct DH infusion of E2 immediately after 
object training can extend the delay at which ovariectomized mice are able to recall training 
objects or locations, and that this enhanced memory consolidation depends on E2-mediated 
activation of the extracellular signal-regulated kinase (ERK) and mammalian target of rapamycin 
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(mTOR) cell-signaling pathways in the DH (Fernandez et al., 2008; Fortress et al., 2013).  
Recently, we showed that E2-induced increases in spinogenesis in both the DH and mPFC also 
rely on activation of ERK and mTOR signaling in the DH, highlighting putative systems-level 
interactions between these brain regions that may be important for memory formation in 
female rodents.  However, the extent to which medial prefrontal-hippocampal interactions are 
necessary for the memory enhancing effects of DH-infused E2 remains unknown.  Further, it is 
also unclear whether E2 can act directly in the mPFC to enhance memory consolidation.    
Therefore, the present study sought to determine the extent to which E2 in the mPFC 
regulates object recognition and spatial memory consolidation, and the necessity of DH-mPFC 
interactions for the memory-enhancing effects of DH E2 infusion.  We first delivered E2 directly 
to the mPFC of ovariectomized mice immediately after object training to assess the effects of 
mPFC-E2 infusion on episodic memory consolidation.  Next, we utilized Designer Receptors 
Exclusively Activated by Designer Drugs (DREADDs) to inactivate the mPFC immediately prior to 
DH E2 infusion to determine whether communication between the DH and mPFC is necessary 
for DH-infused E2 to enhance memory consolidation and increase DH and mPFC dendritic spine 
density in ovariectomized mice. We found that E2 enhanced object recognition and spatial 
memory consolidation when infused into the mPFC, and that chemogenetic inactivation of the 
mPFC prevented DH-infused E2 from enhancing both types of memory. These data suggest an 
important role for E2 in the mPFC in mediating memory formation, and indicate that the mPFC 
and DH interact to mediate the memory-enhancing effects of E2 in ovariectomized mice. 
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MATERIALS AND METHODS 
Subjects.  All experiments used young (9-12 week-old) female C57BL/6 mice (Taconic, 
Cambridge City, IN). Mice were housed in groups of up to five until surgery, after which they 
were singly housed.  Mice were maintained on a 12 h light/dark cycle with ad libitum access to 
food and water. All experimental protocols and procedures were approved by the University of 
Wisconsin-Milwaukee Institutional Animal Care and Use Committee and are in accordance with 
National Institutes of Health guidelines or Guide for the Care and use of Laboratory Animals.  
 
Surgeries. All mice were bilaterally ovariectomized as previously described (Tuscher et al., 
2016; Kim et al., 2016) and were then implanted with bilateral cannulae into the mPFC or DH as 
described below. DH-cannulated mice were also injected into the mPFC with DREADD virus as 
described below.  Ovariectomy, cannulae implantation, and virus injections occurred during the 
same surgical session.  
mPFC cannulation. Mice were anesthetized with isoflurane (5% for induction, 2% for 
maintenance) in 100% oxygen and placed in a stereotaxic apparatus (Kopf Instruments, 
Tujunga, CA). Immediately after ovariectomy, mice were implanted with stainless steel bilateral 
guide cannulae (Plastics One, Roanoke, VA) aimed at the mPFC (1.8 mm AP, ±0.3 mm ML, -2.3 
mm DV), and cannulae were fixed to the skull with dental cement (Darby Dental Supply, New 
York, NY) that served to close the wound.  Dummy cannulae were used to prevent clogging of 
the cannula tracts. Mice received carprofen MediGel one day prior to surgery, as well as a s.c. 
injection of 5 mg/kg Rimadyl at the completion of surgery.  Mice were given 1 week for 
recovery prior to behavioral testing.   
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mPFC DREADD delivery and DH cannulation.  Immediately following ovariectomy, an 
incision was made in the scalp to expose the skull, and small perforations were made in the 
skull with a 26 ½ GA needle to create openings for mPFC viral injections and DH guide cannula 
implantation. Viral injections were made into the mPFC (1.9 mm AP, ±0.3 mm ML, -2.8 mm DV) 
using a 10-µl Hamilton syringe (Hamilton, Reno, NV), which was first lowered to -2.8 mm 
ventral to the surface of the skull and held in place for two minutes to create a pocket for the 
first virus injection.  The syringe was then raised 0.1 mm, and hM4Di DREADD virus (AAV-
CamKII-HA-hM4Di-IRES-mCitrine, 2.1x1012 particles/ml, serotype 8, UNC Vector Core, Chapel 
Hill, NC), eGFP control virus (AAV-CamKII-eGFP, 2.1x1012 particles/ml, serotype 8, UNC Vector 
Core, Chapel Hill, NC), or saline (Sham condition) was delivered at a rate of 0.2 µl/minute over a 
two-minute period, for a total of 0.4 µl per infusion. Injection volume and flow rate were 
controlled by a syringe pump (KD Scientific, Holliston, MA).  After the first infusion, the syringe 
was raised 0.2 mm, and a second infusion of the same volume was delivered at the same rate 
for a total of 0.8 µl per hemisphere.  The Hamilton syringe was left in place 8 minutes after each 
injection to allow for diffusion of the virus, and was then slowly retracted.  After completion of 
virus injections, mice were implanted with stainless steel bilateral guide cannulae (Plastics One, 
Roanoke, VA) aimed at the DH (-1.7 mm AP, ±1.5 mm ML, -2.3 mm DV) as described previously 
(Tuscher et al., 2016, Kim et al., 2016).  Cannulae were fixed to the skull with dental cement 
(Darby Dental Supply, New York, NY) and dummy cannulae were used to prevent clogging of 
the cannula tracts.  Mice received pre- and post-surgical analgesia as described above. Mice 
were then given 3 weeks for recovery and to allow adequate time for the virus to express prior 
to behavioral testing. 
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Drugs and Infusions. Intracranial infusions into the mPFC or DH were conducted as described 
previously (Fernandez et al., 2008; Zhao et al., 2010; Zhao et al., 2012; Fortress et al., 2013). 
Briefly, cyclodextrin-encapsulated 17β-E2 (Sigma-Aldrich, St. Louis, MO) was dissolved in sterile 
0.9% saline to a concentration of 10 µg/µl, and was infused bilaterally into the DH or mPFC 
immediately after object training. Vehicle infusions consisted of 2-hydroxypropyl-β-cyclodextrin 
(HBC; Sigma-Aldrich, St. Louis, MO) dissolved in saline to the same concentration of 
cyclodextrin present in the cyclodextrin-encapsulated E2 solution.  All infusions were conducted 
at a rate of 0.5 μl/min for 1 min per hemisphere as described previously (Fernandez et al., 2008; 
Zhao et al., 2010; Zhao et al., 2012; Fortress et al., 2013), resulting in a dose of 5 µg E2 per 
hemisphere. Mice with mPFC or DH cannulae were infused with HBC vehicle or 5 µg 
E2/hemisphere immediately after object training (see below). 
For DREADD experiments, stock solutions of clozapine-n-oxide (CNO, Cayman Chemical, 
Ann Arbor, MI) were first prepared by dissolving CNO in 100% dimethyl sulfoxide (DMSO, Fisher 
Scientific, Pittsburgh, PA) at a concentration of 100 mg/ml, and stored in 10 µl aliquots at -20 
oC.  On the day injections were administered, CNO stock was thawed and diluted to a 
concentration of 1 mg/ml in a solution of sterile 0.9% saline containing 2% DMSO.  Mice were 
injected i.p. with 1 mg/kg CNO immediately after object training, followed immediately by an 
infusion of HBC vehicle or 5 µg E2/hemisphere into the DH. 
 
Behavioral Testing. Object recognition (OR) and object placement (OP) were used to measure 
object recognition and spatial memory as we have described previously (Boulware et al., 2013; 
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Fortress et al., 2013; Kim, 2016).  Work from our laboratory (Gresack and Frick, 2006; 
Fernandez et al., 2008) and others (Luine et al., 2003; Li et al., 2004; Walf et al., 2008) has 
established that each of these tasks is sensitive to E2 and involves the DH (see Tuscher et al., 
2015 for review). One week after mPFC cannula implantation surgery or three weeks after 
DREADD surgery, mice were handled for 1 minute/day for 3 days prior to habituation.  Mice 
were then habituated to the apparatus for 2 consecutive days by allowing them to explore the 
empty white arena (60 cm x 60 cm x 47 cm) for 5 minutes/day. For object training, mice must 
first accumulate 30 seconds exploring 2 identical objects placed 5 cm from the upper left and 
right corners of the arena. Immediately after training, mice were injected or infused as 
described above and then returned to their home cage. These post-training injections allowed 
us to pinpoint the effects of infusions and DREADD-mediated inactivation specifically to the 
memory consolidation period while minimizing potential confounding effects of performance 
factors (e.g., motivation, anxiety) on the measurement of memory consolidation (McGaugh, 
1989; Frick and Gresack, 2003).  Mice that did not meet the 30 second criterion for object 
exploration were not infused or injected, and were not included in subsequent testing. OR 
memory was then tested 48 hours later by measuring the amount of time spent with the novel 
and familiar object. Intact OR memory consolidation was demonstrated if the mice spent more 
time than chance (15 seconds) with the novel object during testing.  Training and testing for OP 
were identical to OR, except that testing was conducted 24 hours after training, and involved 
moving one of the identical training objects to a new location in the arena during testing. The 
48- and 24-hour delays between training and testing in OR and OP, respectively, were used 
because mice infused with E2 into the DH demonstrate enhanced OR and OP memory 
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consolidation at these time points relative to chance and vehicle-infused mice (Kim et al., 2016, 
Tuscher et al., 2016, Fortress et al., 2013, Boulware et al., 2013).  All mice were trained and 
tested in both behavioral tasks.  To counterbalance the order in which behavior was completed, 
half of the mice completed OR first, followed by OP, and the other half completed OP first, 
followed by OR.  
 
Histological verification of DREADD expression. Three weeks after surgery, mice were 
anesthetized with isoflurane and perfused with 4% paraformaldehyde (PFA) in 1X phosphate-
buffered saline (PBS). Whole mouse brains were then removed and post-fixed in 1X PBS/4% PFA 
overnight, followed by dehydration in a 1X PBS/30% sucrose solution until the brains had sunk. 
Tissue was sectioned on a cryostat (40 µm) and free-floated in 1X PBS until mounted onto 
microscope slides (VWR, Arlington Heights, IL) using aqueous mounting medium containing the 
nuclear stain DAPI (Santa Cruz, Dallas, TX).  Fluorescent images were captured using an 
Olympus Fluoview FV1200 confocal microscope and accompanying software.    
 
Golgi staining and spine counting. Two weeks after the completion of behavioral testing, mice 
(n=7-8/treatment group) were injected i.p. with 1 mg/kg CNO, followed by DH infusion of HBC 
vehicle or E2.  Mice were killed two hours later and whole brains were subjected to Golgi 
staining to assess E2-mediated spine density changes in the DH and mPFC.  Brains were 
collected 2 hours post-infusion because we have previously observed a significant increase in 
spine density in both brain regions two hours after DH E2 infusion (Tuscher et al., 2016).  
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Therefore, this design allowed us to determine if hM4Di-mediated inhibition of the mPFC 
prevents E2-mediated increases in spine density in the DH and mPFC.   
Brain tissue for Golgi staining was collected as described above, two weeks after the 
completion of behavior (n=7-8/treatment group). Golgi impregnation was performed as 
described previously (Frankfurt et al., 2011) using the Rapid GolgiStain Kit (FD 
NeuroTechnologies, Columbia, MD).  Briefly, secondary basal dendrites and tertiary apical 
dendrites were counted blindly from pyramidal neurons in dorsal hippocampal CA1 and layer 
II/III of the mPFC.  Dendrites from 6 cells/region/brain were included in the analysis, and 5-7 
brains were quantified/group.  Neurons in all areas were chosen for analyses as follows: 1) cell 
bodies and dendrites were well impregnated, and 2) dendrites were continuous and clearly 
distinguishable from adjacent cells.   Spines were counted on an Olympus BX51WI microscope 
under oil (100x) using Neurolucida, version 11.08 (MBF Bioscience, Williston, VT).  Spine density 
was calculated by dividing spine number by dendrite length, and data expressed as number of 
spines/10 µm dendrite.   
 
Data analysis.  All statistical analyses were conducted using GraphPad Prism 6 (La Jolla, CA).  To 
determine whether each group demonstrated intact memory for each behavioral task, OR and 
OP data were first analyzed using one sample t-tests to determine if the time spent with the 
novel or moved object differed significantly from chance (15 seconds; Kim et al., 2016, Tuscher 
et al., 2016b).  This analysis was used because time spent with the objects is not independent; 
time spent with one object reduces time spent with the other object (Frick and Gresack, 2003).  
For mPFC-infusion experiments, student’s t-tests were then used to determine significant 
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differences in performance between vehicle and E2-infused groups, and effect of E2 treatment 
on spine density within each brain region.  Statistical significance for all analyses was 
determined as p ≤ 0.05.  For experiments with more than 2 treatment groups, between-group 
treatment differences for each task were measured using one-way ANOVAs with treatment as 
the independent variable, followed by Fisher’s LSD post hoc tests when appropriate (Kim, 2016; 
Tuscher et al., 2016b). For spine density analyses, one-way ANOVAs or student’s t-tests were 
used to determine the effect of E2 treatment on spine density in each brain region, followed by 
post hoc tests when appropriate.  Statistical significance for all analyses was determined as p ≤ 
0.05.  
 
RESULTS  
Infusion of E2 into the mPFC immediately after training enhances memory consolidation and 
increases mPFC apical spine density 
To determine if E2 can act directly within the mPFC to enhance memory, young female 
mice were ovariectomized and implanted with bilateral guide cannulae aimed at the prelimbic 
region of the mPFC 1 week prior to beginning behavioral training.  Mice were then trained in 
the OR or OP task, and bilaterally infused with HBC vehicle or 5 µg/hemisphere E2 into the 
mPFC immediately after training (n=10-13/group).  OR memory was tested 48 hours after 
training.  Vehicle-infused mice spent no more time than chance with the novel object during 
testing (t(11) = 0.175, p = 0.865; Fig. 14A), suggesting object recognition memory was not intact 
in our control group.  In contrast, mice infused with E2 spent significantly more time than 
chance with the novel object (t(12) = 3.402, p = 0.005; Fig. 14A), demonstrating intact memory 
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for the familiar training object. In addition, E2-infused mice spent significantly more time with 
the novel object than vehicle-infused mice (t(23) = 2.294, p = 0.031; Fig. 14A), suggesting that E2 
in the mPFC enhances object recognition memory consolidation.  Similarly, mice infused with E2 
immediately after OP training spent significantly more time than chance with the moved object 
24 hours later (t(10) = 5.056, p = 0.001; Fig. 14B), whereas vehicle-treated females did not (t(9) = 
0.183, p = 0.859; Fig. 14B).  Moreover, E2-infused mice spent significantly more time with the 
displaced object during testing than the vehicle-infused group (t(19) = 2.500, p = 0.022; Fig. 14B), 
suggesting that E2 in the mPFC can also enhance spatial memory consolidation.  Together, these 
data demonstrate that direct infusion of E2 in the mPFC enhances object recognition and spatial 
memory consolidation in ovariectomized female mice.  
Two weeks after the completion of behavioral testing, mice were infused into the mPFC 
with their respective vehicle or E2 treatments, and whole brains were collected two hours later 
for Golgi staining and spine density analyses. mPFC-E2 infusion significantly increased mPFC 
apical (t(12) = 3.18, p = 0.008; Fig. 15A), but not basal (t(11) = 1.13, p = 0.28; Fig. 15B), spine 
density relative to vehicle-infused mice by 2 hours after infusion.  No significant differences 
were observed in CA1 apical spine density between mice infused with vehicle or E2 into the 
mPFC (t(12) = 0.43, p = 0.67; Fig. 15C).  These findings demonstrate that E2 can increase spine 
density in the mPFC within two hours of infusion, but does not impact CA1 apical spine density 
at this time point.   
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Fig. 14: Infusion of E2 into the mPFC immediately after training enhances memory 
consolidation  
 
 
 
 
 
 
 
 
 
Fig. 14: Mice infused with E2 directly into the mPFC spent significantly more time than chance (15 s) with 
the moved object (A & C) when tested 24 hours after training, or with the novel object (B & D) 48 hours 
after training.  Mice infused with HBC vehicle into the mPFC did not spend more time than chance with 
the novel or moved objects.  These data suggest that E2 can improve the consolidation of object memories 
by acting directly in the mPFC.  Bars represent the mean ± SEM, *p < 0.05 relative to chance and the 
vehicle group (n=10-13/group).   
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Fig. 15: mPFC E2 infusion increases apical spine density in the mPFC 2 hours later 
 
 
 
 
 
 
 
Fig. 15: Relative to vehicle, apical (A), but not basal (B) spine density was significantly increased in the 
mPFC 2 hours after mPFC infusion of 5 µg E2 per hemisphere. mPFC infusion did not alter apical spine 
density in CA1 (C). Bars represent the mean ± SEM, *p < 0.05 relative to the vehicle group (n=6-
7/group).   
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hM4Di and eGFP viral expression in the mPFC is present 3 weeks post-injection 
DH infusion of E2 increases dendritic spine density in the mPFC, raising the possibility 
that the DH and mPFC might interact to mediate the memory-enhancing effects of DH E2 
infusion. To determine if mPFC activation is necessary for the memory-enhancing effects of DH-
E2 infusion, we silenced the activity of mPFC excitatory neurons using DREADDs.  
Ovariectomzied mice were bilaterally injected with saline (Sham) or an AAV viral vector 
containing either eGFP or the hM4Di DREADD.  This viral construct targets the CaMKII 
promoter, effectively blocking excitatory neurotransmission near the site of injection when 
bound by its ligand CNO (Armbruster et al., 2007; Zhu et al., 2014). The control viral construct 
AAV8-CaMKII-EGFP, which is driven by the same promoter as that used for the DREADD virus 
but lacks the hM4Di gene (Zhu et al., 2014), was used to control for nonspecific virus effects.   
To verify the location and extent of expression of the virus near the injection sites in the 
mPFC, a subset of mice (n=3/group) was injected with the eGFP construct or hM4Di DREADD 
and perfused 3 weeks later (Fig. 9).  EGFP (Fig. 9B & D) and mCitrine-tagged hM4Di (Fig. 9A & C) 
virus was detected throughout the dorsal/ventral extent of the mPFC (including the infralimbic 
and prelimbic regions). 
 
Chemogenetic suppression of neurotransmission in the mPFC immediately after training 
prevents the memory enhancement induced by DH E2 infusion 
Once hM4Di DREADD expression was confirmed 3 weeks after injection, our next goal 
was to examine whether mPFC activation is necessary for the memory-enhancing effects of E2 
infused into the DH.  To address this question, we first had to identify a dose of CNO that did 
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not impair memory on its own.  This was an important first step, in light of recent data 
suggesting that the CNO metabolite clozapine can cross the BBB and affect behavior (Gomez et 
al., 2017).  This step was also essential for ensuring that any DREADD-mediated disruption of 
the memory-enhancing effects of DH-infused E2 resulted from an interaction between neural 
inactivation and E2, rather than DREADD-mediated impairment of memory consolidation in 
general.  To this end, a new set of ovariectomized mice received mPFC injections of saline, 
eGFP, or hM4Di DREADD 3 weeks prior to behavioral training (n=9-11/group). Mice were 
trained in OP and OR, and then received an i.p. injection of 1 mg/kg CNO immediately after 
training (Fig. 16A & B).  Four-hour and 24-hour time points were used because previous work 
has established that vehicle-treated ovariectomized females show intact memory in OP and OR 
at these respective delays (Fortress et al., 2013, Boulware et al., 2013), which allowed us to 
observe any potential memory-impairing effects of DREADD-mediated inactivation. We found 
that post-training injection of 1 mg/kg CNO did not impair OP memory (hM4Di: t(8) = 5.04, p = 
0.001; Sham+eGFP: t(14) = 6.51, p < 0.0001; Fig. 16C) or OR memory (hM4Di: t(5) = 3.32, p = 0.02; 
Sham+eGFP: t(12) = 4.80, p = 0.0004; Fig. 16D) in any treatment condition, as all groups spent 
significantly more time than chance with the moved or novel object during testing. Further, 
Sham+eGFP control mice and hM4Di expressing mice injected with 1 mg/kg CNO did not differ 
in the amount of time spent with the displaced object (t(22) = 0.24, p = 0.81; Fig. 16D), or the 
novel object (t(17) = 0.83, p = 0.42; Fig. 16C), during testing.   Collectively, these data suggest that 
suppression of mPFC neurotransmission using 1 mg/kg CNO is not sufficient to impair either 
spatial or object recognition memory consolidation.   
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Fig. 16: CNO (1 mg/kg) does not impair memory consolidation in mice expressing hM4Di in 
the mPFC  
 
 
 
 
 
 
 
 
After a non-impairing dose of CNO was identified, we next asked if communication 
between the mPFC and DH was necessary for the memory enhancing effects observed after 
infusion of E2 into the DH.  To address this question, a new set of ovariectomized mice received 
mPFC injections of saline, eGFP, or hM4Di DREADD, and were implanted with bilateral DH guide 
C) D) 
Fig. 16: Experimental design for the object placement (A) and object recognition task (B). A 1 mg/kg 
dose of CNO did not impair memory consolidation in the object placement (C) or object recognition (D) 
tasks, as all mice spent significantly more time than chance (15 sec) with the moved or novel object. 
This finding suggests that 1 mg/kg CNO is not sufficient to cause enough hM4Di-mediated suppression 
of the mPFC to impair spatial or object recognition memory consolidation.  Bars represent the mean ± 
SEM, *p < 0.05 relative to chance.   
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cannulae three weeks prior to behavioral training (n=9-11/group).  Immediately after training, 
mice were injected with 1 mg/kg CNO to activate the DREADD, followed immediately by 
bilateral DH infusion of HBC vehicle or 5 µg/hemisphere E2.  We found that DREADD-mediated 
suppression of excitatory neurotransmission in the mPFC immediately after training blocked the 
E2-mediated enhancement of OR memory.  Specifically, Sham, eGFP, or hM4Di groups receiving 
CNO+HBC did not spend significantly more time than chance with the novel object when tested 
48 hours after OR training (Sham: t(10) = 1.85, p = 0.09; eGFP: t(10) = 1.42, p = 0.19; hM4Di: t(9) = 
0.14, p = 0.89; Fig. 17D), suggesting a lack of intact OR memory in all groups.  In contrast, Sham 
or eGFP mice receiving CNO+E2 remembered the familiar training object 48 hours later (Sham: 
t(8) = 4.37, p = 0.002; eGFP: t(8) = 2.78, p = 0.02; Fig. 17D), indicating that sham surgery and the 
eGFP construct did not interfere with the ability of DH-infused E2 to enhance OR memory 
consolidation.  Importantly, the hM4Di group that received CNO+E2 did not spend more time 
than chance with novel object (hM4Di: t(9) = 0.94, p = 0.37; Fig. 17D) during testing, suggesting 
that excitatory neurotransmission in the mPFC is necessary for DH-infused E2 to enhance OR 
memory consolidation. These findings were further supported by a one-way ANOVA, which 
demonstrated a significant main effect of treatment among the six groups (F(5,54) = 5.14, p = 
0.001).  Fisher’s LSD post hoc tests revealed that Sham and eGFP groups receiving DH E2 
infusions spent significantly more time with the novel object than E2-treated hM4Di mice, or 
any group infused with HBC (ps < 0.05; Fig. 17D).  
To determine if mPFC-DH interactions were also necessary for spatial memory 
consolidation, the same mice were tested in the object placement task.  OP training was 
conducted just as OR, although the order of testing varied among mice as described in the 
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Methods.  Immediately after training, mice were injected with 1 mg/kg CNO, followed by 
bilateral DH infusion of vehicle or 5 µg/hemisphere E2.  As with OR, we found that DREADD-
mediated suppression of excitatory neurotransmission in the mPFC immediately after training 
blocked E2-mediated enhancement of OP memory consolidation. Sham, eGFP, and hM4Di 
groups receiving CNO+HBC did not spend significantly more time than chance with the moved 
object when tested 24 hours after OP training (Sham: t(9) = 0.07, p = 0.94; eGFP: t(9) = 0.56, p = 
0.591; hM4Di: t(9) = 0.56, p = 0.59; Fig. 17C), suggesting a lack of spatial memory consolidation 
in all HBC-infused groups.  In contrast, Sham and eGFP mice receiving CNO+E2 displayed intact 
OP memory 24 hours after training (Sham: t(9) = 7.50, p < 0.0001; eGFP: t(9) = 3.34, p = 0.01; Fig. 
17C), suggesting that E2 enhanced spatial memory consolidation in both groups.  However, as in 
OR, the DH E2-mediated memory enhancement in OP was suppressed in the hM4Di group 
receiving CNO+E2, as this group did not spend more time than chance with moved object 
(hM4Di: t(9) = 0.13, p = 0.90) during testing. Similar to OR, this pattern of findings was further 
supported by a one-way ANOVA, demonstrating a significant main effect of treatment (F(5,54) = 
2.79, p = 0.03; Fig. 17C).  Fisher’s LSD post hoc tests revealed that Sham or eGFP mice receiving 
DH E2 infusion spent significantly more time with the moved object than hM4Di mice infused 
with E2, or sham mice infused with HBC (ps < 0.05; Fig. 17C).  Taken together, these data 
suggest that mPFC activation is necessary for DH-infused E2 to enhance memory in the OR and 
OP tasks in ovariectomized mice, and indicates the importance of systems-level interactions for 
hippocampal E2 to regulate both spatial and object recognition memory consolidation in 
females.   
 
71 
 
 
Fig. 17: Chemogenetic suppression of neurotransmission in the mPFC immediately after 
training prevents the memory enhancement induced by DH E2 infusion 
 
 
       
 
 
 
 
 
 
 
Fig. 17: Sham, eGFP or hM4Di groups receiving CNO+HBC did not spend significantly more time than 
chance (15 s) with the moved object when tested 24 hours after OP training (A & C) or with the novel 
object (B & D) 24 hours after training. In contrast, Sham or eGFP mice receiving CNO+E2
 
immediately after 
training did spent significantly more time than chance with the moved and novel objects, displaying intact 
OP and OR memory. However, hM4Di mice treated with CNO+E2
  
immediately after training did not 
demonstrate intact memory, suggesting that DREADD-mediated suppression of the mPFC blocks the 
beneficial mnemonic effects of DH-infused E2. Bars represent the mean ± SEM, *p < 0.05 relative to 
chance, all HBC-infused groups, and the hM4Di-E2 group (n=9-11/group).  +p < 0.05 relative to chance and 
the Sham+HBC-infused and hM4Di-E2 groups (n=9-11/group). 
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DISCUSSION 
The hippocampus has been the focal point of much neuroendocrinology research 
examining how E2 mediates memory formation and neuroplasticity.  More recently, studies 
have begun to address how E2 might impact other brain regions important for regulating 
cognitive function in females, including the mPFC, amygdala, striatum and perirhinal cortex 
(Maeng et al., 2017; Zurkovsky et al., 2007; Gervais et al., 2013).  In the present study, we found 
that delivering E2 directly into the mPFC significantly increased mPFC apical spine density and 
enhanced object recognition and spatial memory consolidation in ovariectomized mice.  These 
data are the first to demonstrate that E2 can act directly within the mPFC to facilitate memory 
consolidation and spinogenesis in female mice.  Such findings are consistent with previous work 
from our laboratory demonstrating that infusion of E2 into the DH can also enhance object 
recognition and spatial memory consolidation and increase dendritic spine density in the DH 
and mPFC within 2 hours (Fernandez et al., 2008; Tuscher et al., 2016, Kim et al., 2016, 
Boulware et al., 2013).  The present data also align well with previous work reporting 
concomitant increases in mPFC dendritic spine density and memory enhancement in OR and OP 
after i.p. injection of E2 (Inagaki et al., 2012, Luine, 2015).  Although the increase in mPFC spine 
density in these studies occurred during a timeframe consistent with enhanced consolidation 
(i.e., 30 min and 4 hours after training), the memory-enhancing effects of E2 could not be 
directly attributed to actions within the mPFC due to the systemic nature of E2 delivery.  Here, 
we found that direct delivery of E2 to the mPFC of ovariectomized mice significantly enhanced 
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memory consolidation and mPFC apical spine density, suggesting that the mPFC plays a critical 
role in E2-mediated enhancement of memory consolidation.   
In contrast to our previous observation that DH infusion of E2 increased basal spine 
density in the mPFC, here, we found direct infusion into the mPFC resulted in an increase in 
apical mPFC spine density.  One potential reason for this discrepancy could be that input from 
the DH after E2 infusion may preferentially synapse onto basal dendrites in the mPFC, while our 
direct infusions in the present study may have had a greater impact on apical tufts near the 
midline, in close proximity to where the infusions occurred.  Another interesting observation is 
that despite DH infusion of E2 significantly increasing mPFC spine density 2 hours after infusion, 
mPFC E2 infusion did not appear to have reciprocal effects in CA1, at least at the 2 hour time 
point.  These data suggest that hippocampal input may exert greater control over the mPFC 
than vice versa, or that mPFC input to the DH may take longer to occur.  However, additional 
time points would need to be evaluated before concluding neural input from the mPFC has no 
effect on spine density changes in the DH.  
The specific cellular and molecular mechanisms through which E2 may regulate memory 
and spinogenesis in the mPFC are currently unclear.  However, given the necessity of ERK 
activation for E2-mediated spine changes in cortical neuron cultures (Srivastava et al., 2008), 
and the requirement of ERK and mTOR activation in the DH for E2-mediated memory 
enhancement and spinogenesis (Fernandez et al., 2008, Fortress et al., 2014, Tuscher et al., 
2016), we suspect that these pathways are also critical for the memory-enhancing effects and 
spine density changes observed after direct mPFC E2 infusion, although this remains to be 
empirically tested.  The specific ERs involved in mediating such effects also remain to be 
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elucidated. ER, ER, and GPER are all expressed in neurons throughout the mPFC (Almey et al., 
2014), so any may play a role.  Recent work suggests that the rapid effects of E2 on hippocampal 
dendritic spine density in ovariectomized mice are at least in part mediated by ER and GPER 
(Phan et al., 2015), therefore, these receptors are prime candidates for further examination in 
future studies.   
 In addition to the direct effects of E2 in the mPFC, the mPFC may also regulate memory 
by influencing the effects of E2 infused into the DH. We examined whether excitatory 
neurotransmission in the mPFC was necessary for DH-infused E2 to enhance memory by 
chemogenetically inactivating the mPFC immediately before DH E2 infusion. Suppressing 
neurotransmission in the mPFC with the inhibitory hM4Di DREADD prevented DH-infused E2 
from enhancing object recognition and spatial memory consolidation in female mice.  These 
findings demonstrate for the first time that mPFC activation is essential for the memory-
enhancing effects of E2 in the DH and illustrate a novel systems-level relationship between 
these brain regions is necessary for mediating the mnemonic effects of E2.   This experiment 
extends our previous work demonstrating that infusion of E2 into the DH of ovariectomized 
mice increases dendritic spine density in the mPFC within 2 hours, an effect that depends on 
activation of ERK and mTOR signaling in the DH (Tuscher et al., 2016).  This work, in 
combination with our present findings, suggests that activation of the mPFC is necessary for the 
E2-mediated enhancement of object recognition and spatial memory consolidation previously 
observed after DH-E2 infusion (Fernandez et al., 2008, Boulware et al., 2013, Fortress et al., 
2013). To ensure that we observed DREADD-mediated suppression of the memory enhancing 
effects of E2, rather than DREADD-mediated impairment in our object tasks, we used a dose of 
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CNO that does not impair memory on its own (Fig. 16). This step was important given recent 
findings showing that the CNO metabolite clozapine can significantly affect brain and locomotor 
behavior (Gomez et al., 2017). The fact that chemogenetic disruption of the mPFC prevents the 
beneficial mnemonic effects of DH-infused E2 suggests these regions communicate during 
object memory consolidation, and lend further behavioral relevance to the E2-mediated spine 
changes we recently observed in the mPFC after DH E2 infusion (Tuscher et al., 2016).   
How might the hippocampus and mPFC interact to facilitate memory formation?  
Accumulating evidence from studies using retrograde tracers supports the existence of at least 
three potential routes of communication between the hippocampus and mPFC: 1) direct 
unilateral projections originating from dorsal CA1 and subiculum to the mPFC (Ye et al., 2017; 
Hoover and Vertes, 2007), 2) unilateral projections between the ventral hippocampus and 
subiculum of the hippocampus to the mPFC (Ferino et al., 1987; Jay et al., 1989; Jay and Witter, 
1991; Cenquizca and Swanson, 2007), and 3) indirect reciprocal connections routed through the 
nucleus reunions of the thalamus or lateral entorhinal cortex (Burwell and Amaral, 1998; 
Hoover and Vertes, 2007; Vertes et al., 2007).  Evidence for the functional relevance of these 
connections is supported by electrophysiological studies demonstrating that tetanic stimulation 
in the ventral CA1/subiculum of anesthetized rats results in stable long-term potentiation (LTP) 
in prefrontal neurons (Laroche et al., 1990; Jay et al., 1992).  Further, LTP between hippocampal 
and prefrontal synapses leads to a persistent (several day) increase in synaptic strength in 
awake behaving rats (Jay et al., 1996), suggesting direct excitatory input from the hippocampus 
to the mPFC.  Accumulating research has also reported temporally-coordinated neuronal 
activity occurs between the hippocampus and mPFC during periods of wakefulness and sleep in 
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rodents, and that this synchronous activity between hippocampal-prefrontal circuitry is 
essential for systems memory consolidation (Jones and Wilson, 2005; Hyman et al., 2010; 
Sigurdsson et al., 2010; Schwindel and McNaughton, 2011).  Given that hippocampal-prefrontal 
neural synchrony appears to be important for memory consolidation in the aforementioned 
studies, it follows that chemogenetic suppression of the mPFC in the present study may have 
disrupted functional connectivity between the DH and mPFC, resulting in impaired 
consolidation of OR and OP memories. 
In congruence with studies noting the importance of coordinated neural activity 
between the DH and mPFC for memory formation, our present findings also indicate that 
systems-level interactions between the DH and mPFC are necessary for DH-infused E2 to 
enhance memory in ovariectomized mice. Although the specific mechanisms through which 
these circuit-level changes occur are unclear at present, it is possible that DH-infusion of 
E2 leads to the activation of cell-signaling cascades and the downstream transcription of genes 
beneficial for memory in projection regions such as the mPFC, and that DREADD-mediated 
suppression of this brain region prevents this activation from occurring.  The idea that neuronal 
activity in the DH can lead to changes in gene expression in projection regions that are essential 
for memory formation is supported by at least two recent studies. One recent report 
demonstrated that disruption of neural input from the DH to the mPFC during contextual fear 
conditioning prevents later reactivation of mPFC engram cells and training-induced increases in 
spine density in the mPFC (Kitamura et al., 2017).  Another study found that injection of Arc 
anti-sense oligonucleotides directly into the DH blocks reactivation-induced increases in 
markers of neural activity (e.g., Arc, pCREB, and pCofilin protein) in both the DH and in the 
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mPFC, and prevents reactivation-induced enhancement of fear memory expression (Ye et al., 
2017).  Further, DREADD-mediated inhibition of DH projection terminals in the mPFC prior to 
reactivation sessions also prevented reactivation-induced increases in fear memory expression 
and memory-associated proteins in the mPFC (Ye et al., 2017).  Both studies provide evidence 
that inhibiting either neurotransmission or translation of a neural activity marker within the DH 
alters cellular activity and spine density in the mPFC, and that this disruption of cellular 
processes during memory formation impairs memory. These findings align with our observation 
that E2-induced enhancements in memory and mPFC spinogenesis that occur after DH-
E2 infusion are prevented by ERK or mTOR inhibition in the DH (Tuscher et al., 2016, Fernandez 
et al., 2008, Fortress et al., 2013).  Together, these findings provide evidence that cellular and 
molecular processes in the DH (e.g., cell-signaling activation, protein translation) influence the 
mPFC.  The present findings expand on this work by demonstrating that disrupting interactions 
between the mPFC and DH after DH E2 infusion prevents estrogenic facilitation of memory 
consolidation.  These findings collectively support a model whereby DH infusion of E2 leads to 
increased excitatory input to or activation of signal transduction pathways in the mPFC, which 
ultimately drives changes in gene expression and/or protein translation essential for 
spinogenesis and memory.   Ongoing studies are evaluating the extent to which DREADD-
mediated inactivation of the mPFC also prevents DH-infused E2 from increasing spine density in 
the DH and mPFC, which may provide additional support for this putative model. 
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SUMMARY AND CONCLUSIONS 
Several lines of converging neuroendocrinology research have supported a role for E2 
modulation of hippocampal physiology, morphology, and synaptic plasticity, as well as 
hippocampus-dependent memory.  However, ERs are expressed in numerous brain regions, 
including the mPFC, that act in concert with the hippocampus to modulate cognitive function. 
Here, we provide evidence that E2 within the mPFC can also regulate mPFC spine density and 
facilitate memory consolidation in female mice, and that E2-mediated enhancement of memory 
requires communication between the DH and mPFC.  Future studies should address whether 
disruption of neurotransmission in the mPFC has reciprocal consequences on protein 
translation and spinogenesis in the DH at additional time points, as bidirectional 
communication is likely necessary between these structures.  Given that disruption of normal 
hippocampal-prefrontal communication has been implicated in a number of psychiatric and 
neurodegenerative disorders (Godsil et al., 2013, Sampath et al., 2017), some of which females 
are at greater risk for developing (i.e., depression, PTSD, AD) (Albert et al., 2015, Tolin and Foa, 
2006, Solomon and Herman, 2009, Zandi et al., 2002, Dye et al., 2012), gaining a better 
understanding of how the hippocampus interacts with other brain regions to support the 
estrogenic regulation of memory will be essential for elucidating the systems-level basis of 
mental disorders, and for developing potential circuit-based therapeutic interventions. 
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CHAPTER FOUR: Summary, future directions and concluding remarks 
 
In summary, we found that the DH and the mPFC play an integral role in both object 
recognition and spatial memory, and likely act in concert for the successful consolidation of 
episodic-like memories.  We also found that infusion of E2 directly into the mPFC can enhance 
memory consolidation and increase mPFC apical spine density, an effect that likely contributes 
to the beneficial mnemonic effects observed.  At present, it does not appear that mPFC infusion 
of E2 can impact spine density in the DH, perhaps suggesting unidirectional regulation of the 
mPFC from afferent DH projections.  However, additional time points will need to be evaluated 
prior to drawing any final conclusions regarding mPFC regulation of the DH. Finally, we 
demonstrated that the mPFC is necessary for DH E2 infusion to facilitate object recognition and 
spatial memory consolidation, further supporting the notion that these brain regions interact 
during E2-mediated memory enhancement.  Although the specific cellular and molecular 
mechanisms that support DH-mPFC interactions during estrogenic memory formation remain to 
be elucidated, a putative mechanism of action is described below. 
 
Proposed mechanism for mPFC-DH interactions that contribute to the estrogenic regulation 
of memory 
E2 has been shown to increase intrinsic excitability and presynaptic glutamate release in 
hippocampal neurons (Woolley, 2006, Oberlander et al., 2016).  Therefore, E2 infusion into the 
DH may lead to increased direct or indirect excitatory glutamatergic input into the mPFC, 
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activating ionotropic (i.e., NMDARs, AMPARs) and/or metabotropic (i.e., mGluRs) glutamate 
receptors expressed in the mPFC (Fig. 18A).  Previous work has demonstrated that NMDAR 
activation is necessary for E2-mediated changes in hippocampal spinogenesis and LTP (Smith et 
al., 2009), and both NMDARs and mGluRs have been directly linked to E2-mediated 
enhancement of object recognition memory (Vedder et al., 2013; Lewis et al., 2008; Boulware 
et al., 2013).  NMDARs, mGluRs, and ERs are all expressed throughout the mPFC, providing a 
potential mechanism through which E2 could directly interact with ERs (after infusion into 
mPFC) or exert indirect effects by increasing presynaptic glutamate release from the DH to 
activate NMDARs and/or mGluRs in the mPFC.  Activation of any of these receptors may then 
lead to downstream initiation of cell-signaling cascades such as ERK or mTOR within mPFC 
neurons, which are necessary for the increase in spine density and E2-mediated memory 
enhancement after DH infusion of E2. This mechanism of action would also be consistent with 
research demonstrating E2 treatment increases ERK phosphorylation in cortical neuron cultures, 
an effect that is required for E2 to increase cortical spine density in vitro.  Our present findings 
suggest that chemogenetic suppression of neurotransmission in the mPFC may then blunt the 
E2-induced increase in excitatory input and prevent synaptic connections from being 
strengthened after E2 infusion, thereby reducing potential synaptic connections formed 
between the DH and mPFC after E2 infusion, and preventing enhanced memory consolidation 
(Fig. 18B). 
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Fig. 18: Proposed mechanism for mPFC-DH interactions that contribute to the estrogenic 
regulation of memory 
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Fig. 18: Schematic for putative interactions between the DH and mPFC that contribute to the estrogenic 
regulation of memory.  (A) E2 infusion into the DH may lead to increased direct or indirect excitatory 
glutamatergic input into the mPFC, activating ionotropic (i.e., NMDARs, AMPARs) and/or metabotropic (i.e., 
mGluRs) glutamate receptors expressed in the mPFC.  Activation of any of these receptors, as well as co-
activation of mPFC ERs, may then lead to downstream initiation of cell-signaling cascades such as ERK or mTOR 
within mPFC neurons, which are necessary for the increase in spine density and E2-mediated memory 
enhancement after DH infusion of E2. (B) Chemogenetic suppression of neurotransmission in the mPFC may 
then blunt the E2-induced increase in excitatory input by exerting opposing effects on neuronal excitability (via 
cAMP reduction and GIRK activation).  This may ultimately prevent synaptic connections between the DH and 
mPFC from being strengthened after E2 infusion, and thus prevent enhanced memory consolidation. 
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FUTURE DIRECTIONS 
 
Examination of direct DH-mPFC projections and intermediary structures through which the 
DH and mPFC may communicate   
Data presented in this dissertation suggest that the mPFC and DH collaborate during 
object memory consolidation, however this work does not definitively establish direct 
monosynaptic communication between the two structures is necessary for episodic memory 
formation.  To more directly address this question in future studies, one might inject inhibitory 
DREADDs (e.g., hM4Di, KORD) into the DH and implant guide cannulae into the mPFC to deliver 
CNO directly to DH projection terminals in the mPFC.  This would allow for selective 
chemogenetic inactivation of DH terminals projecting to the mPFC without affecting receptors 
expressed in neuronal populations directly within the hippocampus.  Similarly, an optogenetic 
approach could be utilized wherein inhibitory opsins (e.g., ArchT, Halorhodopsin) would be 
injected into the DH, combined with optic fiber implantation in the mPFC to optogenetically 
silence DH projection terminals in the mPFC.  Although the present study focused on the 
necessity of neurotransmission in the DH and mPFC for normal episodic-like memory 
consolidation, and therefore used inhibitory DREADDs to evaluate memory impairment after 
inactivation of the DH or mPFC in the object memory paradigm, excitatory DREADDs (e.g., hM3) 
or opsins (e.g., ChR2) could also be used to stimulate neurotransmission between these brain 
regions to examine facilitation of episodic memory consolidation.  Using such an approach 
would allow one to ask how long the window of intact OR and OP memory can be extended via 
optogenetic or chemogenetic stimulation of the DH, mPFC, or DH axons terminating in mPFC.  
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Further, potential intermediary structures through which the DH and mPFC likely communicate 
could be investigated in a similar fashion.  The nucleus reunions of the thalamus and the 
entorhinal and perirhinal cortices are brain regions identified by tract tracing studies as 
potential intermediate routes of neural communication between the DH and mPFC, and as 
such, examining the necessity of these structures in episodic memory formation is another area 
ripe for further investigation. 
 
Bidirectional effects on the cellular and molecular mechanisms that support memory 
formation between DH-mPFC projections  
Although most tract tracing studies suggest the monosynaptic projections between the 
DH and mPFC are not bidirectional, and are instead predominantely unidirectional from the DH 
to mPFC, whether the mPFC exerts control over the DH either directly or indirectly has not been 
addressed.  Despite the fact that we did not see any spine density changes in the DH 2 hours 
after mPFC-E2 infusion, this does not rule out the possibility that other important molecular 
changes may occur in the form of cell-signaling activation or changes in gene transcription.  
Further, spine changes were only examined at a single time point in our present experiments (2 
hours), which does not eliminate the possibility that downstream or feedback-type changes 
occur from mPFC input back to DH at later time points.  As such, it may be worth analyzing 
additional time points beyond 2 hours, or cell-signaling events in the DH earlier than 2 hours 
after mPFC infusion of E2. 
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Elucidation of the molecular mechanisms through which E2 mediates spinogenesis and 
memory enhancement in the mPFC  
 The specific signal transduction cascades through which E2 facilitates memory formation 
in the mPFC also remain to be elucidated.  Given the requirement of DH ERK and mTOR 
activation for E2-mediated enhancement of memory and spine density changes in CA1 and the 
mPFC after DH infusion of E2 (Fernandez et al., 2008, Fortress et al., 2013, Tuscher et al., 2016), 
these pathways are likely also involved in E2’s beneficial mnemonic effects when delivered 
directly into the mPFC.  The likelihood that mPFC spinogenesis is mediated in part by the ERK 
pathway is also supported by in vitro work identifying the necessity of ERK activation for E2-
mediated spine density increases in cortical neuron cultures (Srivastava et al., 2008).  However, 
such questions remain to be empirically tested in vivo.   
 
Epigenetic regulation of E2 sensitive genes in the mPFC  
  Although not the focus of this dissertation, E2 can modify the expression of epigenetic 
enzymes (e.g., DNA methyltransferases, histone deacetylases; Zhao et al., 2010, 2012) which 
likely impact the expression of proteins important for spinogenesis and memory formation.  At 
least one study has demonstrated that E2 can epigenetically regulate the expression of the Bdnf 
gene in the DH of young and middle-aged female mice (Fortress et al., 2014).  However, 
whether E2 epigenetically regulates gene expression in the mPFC is yet to be addressed.  Future 
studies should investigate E2-mediated epigenetic regulation of memory-associated genes in 
the mPFC and other brain regions important for cognitive function, including the amygdala, 
entorhinal and perirhinal cortices and nucleus reunions of the thalamus. 
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The potential contribution of brain-synthesized E2 in the mPFC  
One other relatively novel area of neuroendocrine research is the contribution of E2 
synthesized locally in the brain to memory formation.  Recent work from our lab has provided 
evidence that hippocampal E2 levels are elevated in an experience-induced manner after novel 
object training, and that blocking E2 synthesis directly in the DH of ovariectomized mice impairs 
object recognition and spatial memory consolidation.  However, whether local E2 synthesis is 
also important in the mPFC for object memory consolidation remains an open question. This 
area of research may be increasingly important given that emerging evidence from clinical 
studies suggests that aromatase inhibition, which suppresses endogenous E2 synthesis, may 
negatively impact cognitive function in human females.  For example, aromatase inhibitors, 
which are used to treat hormone-receptor positive forms of breast cancer (Geisler et al., 2002, 
Puddefoot et al., 2002), are reportedly associated with impaired working memory, 
concentration, and performance in verbal and visual memory tasks (Collins et al., 2009, Bender 
et al., 2007, Bender et al., 2015). Therefore, gaining a better understanding of how aromatase 
inhibition impacts E2 synthesized locally in the brain, and what the consequences of such 
inhibition are on the circuitry that supports cognitive function, will be particularly important for 
future studies to address.     
 
CONCLUDING REMARKS 
The hippocampus has been the focal point of much neuroendocrinology research the 
past 25 years.  This is in part due to seminal work published in the early 1990s by Bruce 
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McEwen that expanded the scope of neuroendocrinology research in rodents beyond the 
confines of brain regions involved in regulating reproduction and sexual maturation. This work, 
demonstrated that brain regions important for learning and memory such as the hippocampus 
were also responsive to estrogens, and ignited an entire new subfield of research dedicated to 
the effects of estrogens on cognition.  Only more recently has research on E2-mediated effects 
on neuroplasticity and memory been extended to other brain regions important for regulating 
cognitive function in females, including the mPFC, amygdala, striatum, and perirhinal cortex 
(Maeng et al., 2017; Zurkovsky et al., 2007; Gervais et al., 2013).  This expanded perspective, 
including hippocampal interactions with other brain regions that support a variety of cognitive 
processes, will be critical for gaining a more comprehensive, circuit-level understanding of the 
estrogenic regulation of memory.  Although this dissertation used a model of episodic-like 
memory without aversive or appetitive components to address questions about the role of E2 in 
memory, the DH and mPFC collaborate to create and store other types of memoriesthat have 
important implications for neuropsychiatric disorders like addiction, depression, and PTSD.  
Given that several psychiatric disorders including depression, anxiety, and PTSD 
disproportionately affect more females relative to males (Albert et al., 2015, Tolin and Foa, 
2006, Solomon and Herman, 2009), and that loss of E2 during middle age can increase 
susceptibility to neurodegernative diseases like AD (Alzheimer Association, Zandi et al., 2002, 
Dye et al., 2012), gaining a better understanding of systems-level interactions between the 
hippocampus and other brain regions regulated by E2 will be particularly important for the 
future of neuroendocrinology research. 
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